Abstract
The dissociation rate (k off) associated with ligand unbinding events from proteins is a parameter of fundamental importance in drug design. Here we review recent major advancements in molecular simulation methodologies for the prediction of k off. Next, we discuss the impact of the potential energy function models on the accuracy of calculated k off values. Finally, we provide a perspective from high-performance computing and machine learning which might help improve such predictions.
Keywords: kinetics, drug discovery, QM/MM, parallel computing, machine learning, enhanced sampling, molecular dynamics
1 Introduction
The kinetics of drugs unbinding from proteins is an important parameter for the drugs’ efficacy. (Pan et al., 2013; Copeland, 2021). Indeed, the drug-target residence time (Copeland, Pompliano and Meek, 2006) defined as the inverse of the dissociation rate k off, has emerged as an effective surrogate measure of in vivo target occupancy, and it has been shown to correlate with clinical efficacy (Guo et al., 2012; Lee et al., 2019; Van Der Velden et al., 2020) along with other factors (e.g., association rates (Folmer, 2018; Lee et al., 2019) and target saturation (de Witte et al., 2018)). Residence time has been related not only to long-lasting pharmacodynamics but also to the reduced toxicity of specific inhibitors (Vauquelin et al., 2012).
Experimental approaches (most often combined with computations) measure ligand affinities and provide ligand binding poses for structure-based drug design campaigns (Durrant and McCammon, 2011; De Vivo et al., 2016; Proudfoot et al., 2017; Emwas et al., 2020; Mazzorana et al., 2020). They routinely also measure k off values (Pollard, 2010). However, they cannot usually access the structural determinants of the transition states associated with ligand unbinding. This information would be crucial to eventually design ligands with longer residence times. In contrast, all-atom molecular simulations (in particular molecular dynamics (MD)) can provide a detailed map of protein-ligand interactions and the atomic rearrangements that drive ligand unbinding. However, the residence time of tight binders can be as long as several hours (Li et al., 2014), much longer than the timescales reached by plain MD (milliseconds on dedicated, specialized machines) (Pan et al., 2019; Shaw et al., 2021). Thus, k off predictions based on such a straightforward approach so far have been few in number (Pan et al., 2017) or limited to model systems (Tang and Chang, 2018).
Enhanced sampling is a more general approach to the estimation of k off, regardless of the timescale of the unbinding event. One group of methods (including metadynamics, Gaussian Accelerated MD, scaled MD, and dissipation-corrected targeted MD) employs biasing potentials designed to reduce the free energy barrier determining the frequency of dissociations. Because the bias affects the dynamics, correction terms are required to recover the unbiased k off from the biased rates. A second group is represented by path sampling approaches such as weighted ensemble and milestoning. These rigorously generate an ensemble of trajectories by iteratively restarting the (unbiased) simulations from selected configurations (typically closer to the transition state than expected from the equilibrium distribution) with the aim of increasing the likelihood of observing dissociations. Finally, Markov state models (MSMs) can provide a complete picture of the metastable states of the system and transition rates between them by analyzing molecular simulation data.
In this review, we summarize principles and applications of the three approaches outlined above (Sections 2–4). Next, we discuss the impact of force fields on the accuracy of the calculations (Section 5). Finally, we provide a perspective on how machine learning, along with exascale computing, could constitute one way to address these challenges (Section 6).
1.1 Scope
Many methods have been developed for the calculation of rate constants in biomolecular simulations. Here, we review methodologies that have been applied to the calculation of binding dissociation rates (k off) of protein-ligand complexes with a focus on the effect of the potential energy function. In particular, for the sake of conciseness, we do not cover methods that have been applied only to other types of systems/problems (e.g., supramolecular host-guest dissociations, peptide folding rates) and methods that enable relative comparisons of k off between different ligands. 1 For these methods, we refer the reader to the other excellent resources on the topic (Chong et al., 2017; Bruce et al., 2018; Nunes-Alves et al., 2020).
2 Biased MD Methods
In this class of methods, the system is biased (by adding a potential term to the Hamiltonian, or adding external forces) to favor the observation of unbinding events. The bias is designed to enhance the exploration along low-dimensional collective variables (CV), which are represented as differentiable functions s(x) of the atomic coordinates x. These describe the slow degrees of freedom governing the unbinding process. The CV must be able to distinguish the metastable states involved in the process i.e., configurations in different states should correspond to different values of the CV. The identification of optimal CVs (whenever they are not intrinsic in the technique) is a complicated task, and their identification is at the center of a heated debate that is still open (Sittel and Stock, 2018). Because biasing terms alter the dynamics, methods which recover the kinetic parameters of the unbiased system from its free energy surface have been devised. The majority of biased methods adopt specific corrections based on Kramers’ rate theory
(1) |
where k AB is the rate of transition from state A to B (in this case the bound and unbound states), is typically associated with the curvature of the free energy surface, is the transmission coefficient, and and are the configurational partition functions of the transition state and state A, respectively. These methods require the identification of the transition state ensemble, defined as the set of conformations of highest free energy along the (un)binding pathway. This is in general a challenging task for drug binding processes, which can involve multiple dissociation pathways due to the conformational flexibility of the protein (Plattner and Noé, 2015). Approaches of this kind have been developed for Gaussian accelerated molecular dynamics (Miao et al., 2020) (see Section 2.1), dissipation-corrected Targeted Molecular Dynamics (Wolf and Stock, 2018) (see Section 2.2), and τ-random acceleration molecular dynamics (Kokh et al., 2018) (see Section 2.3) 2 . If no bias is deposited on the region of the transition state(s), the kinetic correction can be assumed not to depend on and (Voter and Doll, 1985; Hänggi et al., 1990; Truhlar et al., 1996). This simplifies dramatically the rate estimation, and it is used for ligand unbinding in the kinetics-oriented flavors of metadynamics (Tiwary and Parrinello, 2013; Wang et al., 2018) (see Section 2.4).
2.1 Ligand Gaussian Accelerated MD
2.1.1 Basic principles
In this approach (Miao, 2018), two harmonic potentials are added to the non-bonded component of the potential energy so as to lower the binding/unbinding free energy barrier (Figure 1). These potentials act on the following CVs: 1) the ligand-environment potential energy and (optionally) 2) the rest of the system potential energy. Both biasing potentials are capped at user-defined thresholds. Computing the correction to recover the unbiased transition rate requires the estimation of the potential of mean force (PMF) profile and free energy barrier as a function of a separate CV describing the binding process e.g., a distance between ligand and protein atoms (Miao, 2018). In the closely related Pep-GaMD method, developed specifically for simulating peptides unbinding from their target protein, the harmonic “boost” potentials are applied to the total potential (both non-bonded and bonded components) along the CVs (Wang and Miao, 2020). The application of the additional boost potential to the bonded component of the peptide potential energy accelerates the sampling of its conformational flexibility.
2.1.2 Applications
So far, the approach has been successfully applied to the ligand benzamidine targeting the trypsin enzyme (Miao, Bhattarai and Wang, 2020), using the AMBER14SB (Maier et al., 2015) and GAFF (Wang et al., 2004) force-fields. The calculated k off = 3.53 ± 1.41 s−1 was two orders of magnitude smaller than the experimental value of 600 ± 300 s−1 (Guillian and Thusias, 1970). The simulations required a cumulative 5 μs of MD for the estimation of k off. Pep-GaMD has been used to investigate the un/binding of three model peptides that target the SH3 domain—one of which (PDB:1CKB) has an experimentally determined k off available for comparison to the computed value. Employing the AMBER14SB (Maier et al., 2015) force field and an aggregate simulation time of 3 μs, a k off of 1.45 ± 1.17 ⋅ 103 s−1 was computed for 1CKB; a result that is in close agreement with the experimental value of 8.9 ⋅ 103 s−1 (Xue et al., 2014).
2.2 Dissipation-Corrected Targeted Molecular Dynamics (dcTMD)
2.2.1 Basic principles
This method (Wolf and Stock, 2018) assumes that unbinding processes (along with binding processes) can be described by the 1-dimensional Langevin dynamics of a suitable CV. The approach requires the determination of the free energy profile and the Langevin friction coefficient as a function of such a CV. These can be calculated from a nonequilibrium targeted molecular dynamics simulation (Schlitter et al., 1994) (see Supplementary Material S4), where a pulling force drives the system at a constant speed along the CV. Dissociation rates could then be obtained by performing the unbiased 1-dimensional Langevin dynamics simulations (Wolf and Stock, 2018). Despite the simplification, the timescales of ligand unbinding processes at room temperature still lead to prohibitively expensive simulations. To tackle this problem, the authors later introduced an approach that uses Kramers’ theory to correct the rates obtained from Langevin simulations performed at higher temperatures. (Wolf et al., 2020).
2.2.2 Applications
The method has been successfully applied to the calculation of k off of the trypsin-benzamidine complex, and the complex between a resorcinol scaffold-based inhibitor and the HSP90 protein. The calculated values 270 ± 40 s−1 and 1.6 ± 0.2 ⋅ 10–3 s−1 respectively, agree well with the experimental values of 600 ± 300 s−1 (Guillian and Thusias, 1970) and 3.4 ± 0.2 ⋅ 10–2 s−1 (Amaral et al., 2017) These predictions required an aggregate of ∼ 1.5 × 104 ms of Langevin simulations and used the AMBER99SB* force-field (Best and Hummer, 2009).
2.3 τRAMD
2.3.1 Basic principles
The τ-random acceleration molecular dynamics (τRAMD) (Kokh et al., 2018) protocol is a quasi-biased method that evolved from random acceleration molecular dynamics (RAMD) (Lüdemann et al., 2000). τRAMD simulations of ligand-protein systems proceed similarly to standard MD simulations, without the need for any prior parameter fitting, characterization of CVs or binding pathways. The user specifies the magnitude of a randomly oriented force that is applied to the ligand to accelerate its dissociation from the binding pocket at each checkpoint, allowing for the observation of dissociation pathways within several nanoseconds of simulation time. The magnitude of the force dictates the duration of simulation time that is required and is reported to have a minimal effect on the accuracy of computed residence times. The direction of the force is reassigned after each checkpoint until the ligand COM moves past a certain distance threshold from its previous position. If the deviation of the ligand COM meets or exceeds this threshold after the force is applied, the direction of the force is retained until the following checkpoint. An ensemble of unbinding simulations is spawned from different starting configurations and velocities, and the ensemble-averaged residence time is calculated from the bootstrapped distribution of the time taken for dissociation to occur.
2.3.2 Applications
The earliest applications of τRAMD for unbinding kinetics focused on qualitatively ranking ligands according to their computed k off values (see Supplementary Material S5) (Kokh et al., 2018, 2019, 2020). Recently, the first quantitative τRAMD application was demonstrated by Maximova and co-workers (Maximova et al., 2021), who formulated a Kramers’ rate theory-based rescaling factor to correct for the influence of the applied force on the receptor-ligand coupling (which previously limited the method to qualitative ranking) to obtain a quantitative k off estimate for the drug Isoniazid unbinding from the catalase enzyme. Using seven trajectories (with applied forces of different magnitudes), and the CHARMM36 forcefield (Best et al., 2012), a k off of 2.8 ± 3.7 ⋅ 10–2 s−1 was computed—a result which agreed very well with the experimental equivalent of 2.0 ± 0.3 ⋅ 10–2 (Singh et al., 2008).
2.4 Metadynamics-Derived Methods
2.4.1 Basic principles
Well-tempered Metadynamics (MetaD) (Laio and Parrinello, 2002) is an exact free-energy method (Barducci et al., 2008; Dama et al., 2014). It draws inspiration from earlier CV-based enhanced sampling techniques such as local elevation (Huber et al., 1994), Wang-Landau (Wang and Landau, 2001), conformational flooding (Grubmüller, 1995), and adaptive umbrella sampling techniques (Hooft et al., 1992; Bartels and Karplus, 1997). In MetaD, a history-dependent bias potential B t (s) is built iteratively by adding Gaussian functions (as approximations of CV histograms) to the potential at regular intervals throughout the simulations. Several different bias-deposition schemes have been devised (Bussi and Laio, 2020). Ultimately, convergence is achieved when the sum of the free energy surface and the bias potential produces a flat landscape that results in diffusive dynamics in CV space (see Figure 2). It is then possible to compute the free energy surface along the CV via reweighting methods, such as Weighted Histogram Analysis Method (WHAM) (Kumar et al., 1992), Multistate Bennet Acceptance Ratio (MBAR) (Shirts and Chodera, 2008), or other estimators (Tiwary and Parrinello, 2015; Schäfer and Settanni, 2020).
MetaD has been extended to allow recovery of the kinetics of the unbiased ensemble. The method speeds up the calculation of kinetic rates by filling up the starting free energy basin so as to reduce the activation free energy barrier to ∼ k BT. This way, the biased residence time of the system in the initial state is small enough to allow multiple observations of the transition. Transition times obtained in the biased ensemble are then scaled to recover the unbiased kinetics. Following the approaches of Grubmüller (Conformational flooding (Grubmüller, 1995)) and Voter (Hyperdynamics (Voter, 1997)) the unbiased transition time is connected to the biased time by:
(2) |
where β =(k BT)−1, Bt(s) is the history-dependent bias potential, and Δt is the time step. For this last equation to be valid, no bias should be present on the transition state. In the so-called infrequent MetaD variant (Tiwary and Parrinello, 2013), the Gaussians are deposited less frequently in barrier regions than they are in standard MetaD, thus lowering the probability of adding bias to the transition state. In frequency-adaptive (FA) MetaD (Wang et al., 2018), the time interval between bias depositions is gradually increased as the system approaches the transition state. After an initial fast filling of the free energy minimum, the same deposition rate as infrequent MetaD is achieved. This way, results are obtained at a lower computational cost compared to standard infrequent MetaD. Recently, an alternative method to infrequent and frequency-adapted MetaD has been presented. (Ansari et al., 2022) This method builds on a variant of MetaD called on-the-fly probability enhanced sampling (OPES). (Invernizzi and Parrinello, 2020) In the new approach, called OPES-flooding, the bias is constructed in a fast but controlled manner to fill the starting metastable basin up to a user-defined threshold value to automatically avoid depositing bias on the transition state. Usually, the standard protocol adopted in infrequent, FA-MetaD and OPES-flooding consists of running multiple independent simulations that yield an empirical distribution of residence times. A statistical analysis based on the Kolmogorov-Smirnov (KS) test (Salvalaglio et al., 2014), details in Supplementary Material S1) is then used to verify a posteriori that the transition state was indeed untainted.
2.4.2 Applications
Infrequent MetaD simulations based on the OPLS force-field (Kaminski et al., 2001) were used to study the unbinding of the ligand dasatinib from its target c-Src kinase (Tiwary et al., 2017). The CVs were the distance between the ligand and the binding pocket and the solvation state of the binding pocket. The calculated k off of 4.8 ± 2.4 ·10–2 s−1 of dasatinib to c-Src obtained from 12 unbinding trajectories agreed well with an experimental value (5.6 · 10–2 s−1, measured indirectly from k on) published by (Shan et al., 2009), but differed from a second value obtained for a fluorophore-tagged analogue (1.8 · 10–4 to 7.9 ⋅ 10–4 s−1) (Kwarcinski et al., 2016). A similar protocol was used to calculate k off for 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)urea), an inhibitor of p38 MAP II kinase belonging to the BIRB-796 family, this time using AMBER99SB-ILDN (Hornak et al., 2006; Lindorff-Larsen et al., 2010) and GAFF force-fields (Wang et al., 2004; Wang J. et al., 2006). After 17 independent unbinding events, the calculated k off (0.020 ± 0.011 s−1 (Casasnovas et al., 2017)) was almost one order of magnitude lower than the experimental value of 0.14 s−1 (Regan et al., 2003). Two other CVs yielded very similar results simulating 10 unbinding events each, suggesting that the discrepancy between the calculated and experimental values most likely arises from uncertainty in the force field rather than the choice of CVs.
FA-MetaD and Infrequent MetaD were used by Wang and co-authors (Wang et al., 2018) to obtain k off values for benzene and indole ligands from the binding pocket of the L99A mutant of T4 lysozyme using CHARMM22 (MacKerell et al., 1998; MacKerell et al., 2004) and CGenFF (Vanommeslaeghe et al., 2011). The calculated k off for benzene lay within the range of 4–10 s−1, around 100-fold lower than the experimental value of 950 ± 20 s−1 (Feher et al., 1996). Both MetaD protocols used the same force-field, sample size (20 replicas), and path-CVs (Branduardi et al., 2007; Wang et al., 2017). CHARMM36-based (Best et al., 2012) infrequent MetaD simulations (Mondal et al., 2018) yielded a k off for benzene (270 ± 100 s−1) that was considerably closer to the experimental value. Although only the displacement between binding pocket and ligand centers-of-mass was used as the CV, and the sample size was smaller than that of the previous study by Wang et al, it is tempting to conclude that even a different version of the same force-field (CHARMM in this case) may significantly impact the result.
More recently, AMBER14SB-based (Maier et al., 2015) FA-MetaD simulations were applied to study the unbinding kinetics of a radioligand, iperoxo, from the M2 human muscarinic acetylcholine receptor (Capelli et al., 2020). The calculated k off (3.7 ± 0.7 ⋅ 10−4 s−1) was two orders of magnitude smaller than the experimental value (1.0 ± 0.2 ⋅ 10−2 s−1). Density Functional Theory (DFT)-based QM/MM calculations suggested that this estimation discrepancy may be ascribed, at least in part, to the lack of polarization and charge transfer effects lacking in standard biomolecular force fields (Capelli et al., 2020).
OPES-flooding simulations based on AMBER14SB (Maier et al., 2015) and GAFF (Wang et al., 2004) were recently applied to study the unbinding kinetics of the trypsin-benzamidine complex, unveiling the role of water in regulating the residence time. Notably, the authors identified two different unbinding pathways and were able to calculate the corresponding rates separately. The slowest rate of 687 s−1 that is supposed to dominate the residence time is in good agreement with the experimental value of 600 ± 300 s−1 (Guillian and Thusias, 1970).
3 Markov State Models
3.1 Basic Principles
Markov state models (MSMs) (Singhal et al., 2004) are discrete models describing the dynamics of a system in terms of transition probabilities between a finite set of metastable states. The fundamental ingredients of the method are 1) a discretization of the conformational space into (kinetically fast) microstates and 2) a transition matrix that describes the probability of observing the system in another microstate after a fixed lag time t. An interpretable, coarse-grained model is then built by defining kinetically metastable macrostates as collections of microstates, and this model can provide k off values. Figure 3 shows a simplified schematic depiction of the MSM construction pipeline. The lag time t must be long enough to ensure that transitions between states are approximately Markovian 4 and short enough for the model to represent all relevant fast processes. It should be chosen to be faster than association events to avoid systematic overestimation of the residence time (Paul et al., 2017). When this is not possible, k off can still be estimated from rate matrices rather than transition matrices (Kalbfleisch and Lawless, 1985; Crommelin and Vanden-Eijnden, 2009). However, rate matrix estimation is not unique and different approaches can result in residence times that differ even by an order of magnitude (Paul et al., 2017).
The input data to build MSMs can come from an ensemble of unbiased MD trajectories that sample dissociation events. However, generating this data is usually prohibitively expensive. Hence, several powerful schemes have been designed to enable the estimation of second-long residence times from relatively short MD simulations. These include adaptive restarting strategies (Bowman et al., 2010; Wan and Voelz, 2020) and/or biased simulations (Wu et al., 2016; Paul et al., 2017; Stelzl et al., 2017). In particular, recently developed estimators such as transition-based reweighting analysis TRAM (Wu et al., 2016) and its MBAR variant TRAMMBAR (Paul et al., 2017) require only irreversible visits to metastable states in the unbiased MD (as long as these states are sampled reversibly in the biased ones) and can greatly alleviate the sampling problem.
3.2 Applications
MSM calculations on the trypsin-benzamidine complex (Plattner and Noé, 2015) (methodological details in Supplementary Material S6) yielded a k off of 131 ± 109 × 102 s−1, which compares fairly well with experiments (k off = 600 ± 300 s−1) (Guillian and Thusias, 1970). However, the high level of uncertainty suggests that sampling of unbinding events might be insufficient despite the large amount of aggregate simulation time (149.1 μs in this case). The dissociation of benzene from the L99A mutant T4 Lysozyme was investigated in a hybrid MSM/infrequent MetaD study (Mondal et al., 2018) using the CHARMM36 force-field (Best et al., 2012). The MSM was constructed from unbiased MD trajectories, and gave a k off of 310 ± 130 s−1, which was marginally closer to the experimental k off (950 ± 20 s−1) (Feher et al., 1996) than the value reported by the accompanying infrequent MetaD simulations (k off = 270 ± 100 s−1) (Mondal et al., 2018) and considerably closer than the previous FA-MetaD-based predictions (see Table 1) (Wang et al., 2018) However, the statistical uncertainty in the MSM-derived k off was quite large, and the calculation required more simulation time (60 μs) compared biased MD approaches to obtain similar uncertainties: FA-MetaD/Infrequent MetaD studies typically require 6–12 μs (Casasnovas et al., 2017; Wang et al., 2018; Capelli et al., 2020) and LiGaMD (Miao et al., 2020) required ∼ 5 μs.
TABLE 1.
Target | Technique | T [K] | Force field | k off (sim) [s−1] | k off (Exp) [s−1] | Simulation time [µs] | Ref | Year |
---|---|---|---|---|---|---|---|---|
Trypsin/Benzamidine | SEEKR | 298 | Amber14SB + GAFF | 83 ± 14 | 600 ± 300 | 19 | 10.1021/acs.jpcb.6b09388 | 2017 |
Trypsin/Benzamidine | SEEKR | 298 | Amber14SB + GAFF | 174 ± 9 | 600 ± 300 | 4.4 | 10.1021/acs.jctc.0c00495 | 2020 |
Trypsin/Benzamidine | SEEKR2 | 298 | Amber14SB + GAFF | 990 ± 70 | 600 ± 300 | 5 | 10.26434/chemrxiv-2021-pplfs | 2021 |
Trypsin/Benzamidine | M-WEM | 298 | Amber14SB + GAFF | 791 ± 197 | 600 ± 300 | 0.48 | 10.1021/acs.jctc.1c00803 | 2022 |
Trypsin/Benzamidine | Inf-MetaD | 300 | Amber99SB-ILDN | 9.1 ± 2.5 | 600 ± 300 | 5 | 10.1073/pnas.1424461112 | 2015 |
Trypsin/Benzamidine | Inf-MetaD | 300 | Amber14SB + GAFF | 4176 ± 324 | 600 ± 300 | — | 10.1021/acs.jctc.8b00934 | 2019 |
Trypsin/Benzamidine | MSM | 298 | Amber99SB + GAFF | (9.5 ± 3.3)·104 | 600 ± 300 | 50 | 10.1073/pnas.1103547108 | 2011 |
Trypsin/Benzamidine | MSM | — | — | 2.8 ·104 | 600 ± 300 | 7.7 | 10.1021/ct400919u | 2014 |
Trypsin/Benzamidine | MSM | — | Amber99SB + GAFF | 131 ± 109 | 600 ± 300 | 149.1 | 10.1038/ncomms8653 | 2015 |
Trypsin/Benzamidine | MSM | 298 | Amber99SB + GAFF | 1170 [617, 2120] | 600 ± 300 | 58.28 | 10.1073/pnas.1525092113 | 2016 |
Trypsin/Benzamidine | WExplore | 300 | Charmm36 + CGenFF | 5.56 ·104 | 600 ± 300 | 4.1 | 10.1016/j.bpj.2017.01.006 | 2017 |
Trypsin/Benzamidine | REVO | 300 | Charmm36 + CGenFF | 2660 | 600 ± 300 | 8.75 | 10.1063/1.5100521 | 2019 |
Trypsin/Benzamidine | LiGaMD | 300 | Amber14SB + GAFF | 3.53 ± 1.41 | 600 ± 300 | 5 | 10.1021/acs.jctc.0c00395 | 2020 |
Trypsin/Benzamidine | dcTMD | 290 | Amber99SB* | 270 ± 40 | 600 ± 300 | 10000 c | 10.1038/s41467-020-16655-1 | 2020 |
Trypsin/Benzamidine | AMS | 298 | Charmm36 + CGenFF | 260 ± 240 | 600 ± 300 | 2.3 | 10.1021/acs.jctc.6b00277 | 2016 |
Trypsin/Benzamidine | OPES | 300 | Amber14SB + GAFF | 687 | 600 ± 300 | 3.2 | arXiv:2204.05572 | 2022 |
T4L L99A-Benzene | In-MetaD | 300 | Charmm22* | 6.0 ± 2.2 | 950 ± 200 a | 6.7 | 10.1039/c7sc01627a | 2017 |
T4L L99A-Benzene | FA-MetaD | 300 | Charmm22* | 5.7 ± 2.3 | 950 ± 200 a | 5.5 | 10.1063/1.5024679 | 2018 |
T4L L99A-Benzene | In-MetaD | 303 | Charmm36 | 270 ± 100 | 950 ± 200 | — | 10.1371/journal.pcbi.1006180 | 2018 |
T4L L99A-Benzene | MSM | 303 | Charmm36 | 310 ± 130 | 950 ± 200 | 60 | 10.1371/journal.pcbi.1006180 | 2018 |
T4L L99A-Indole | In-MetaD | 300 | Charmm22* + CGenFF | 9.8 ± 10.2 | 325 ± 75 b | 4.5 | 10.1063/1.5024679 | 2018 |
T4L L99A-Indole | FA-MetaD | 300 | Charmm22* + CGenFF | 6.0 ± 3.7 | 325 ± 75 b | 2.0 | 10.1063/1.5024679 | 2018 |
µOpioid receptor-morphine | In-MetaD | 300 | Charmm36 + CGenFF | (5.7 ± 0.5)·10–2 | (2.3 ± 0.2)·10–2 | 6 | 10.1063/5.0019100 | 2020 |
µOpioid receptor-bruprenorphine | In-MetaD | 300 | Charmm36 + CGenFF | (2.1 ± 0.3)·10–2 | (1.8 ± 0.3)·10–3 | 19 | 10.1063/5.0019100 | 2020 |
µOpioid receptor-Fentanyl | In-MetaD | 310 | Charmm36m + CGenFF | (2.6 ± 0.8)·10–2 (HID) (3.8 ± 1.4)·10–1 (HIE) 1.1 ± 0.3 (HIP) | 4.2 · 10–3 | 6 | 10.1021/jacsau.1c00341 | 2021 |
TSPO-PK11195 | REVO | 300 | Charmm36 + CGenFF | (D1)6.4 · 10–5 (D2)6.67·101 (D3)6.4 · 10–3 (D4)4.1 · 10–3 (4RYI)6.0 · 10–4 (D1-D4 different docked poses) | 4.9 · 10–4 | 40 | 10.1016/j.bpj.2020.11.015 | 2021 |
c-Src kinase-dasatinib | In-MetaD | 300 | OPLS | (4.8 ± 2.4)·10–2 | 5.6 · 10–2 1.1 · 10–3 | ∼7–8 | 10.1126/sciadv.1700014 | 2017 |
Src kinase - imatinib | TS-PPTIS | 305 | Amber99SB*-ILDN + GAFF (QM/MM) | 0.026 | 0.11 ± 0.08 | — | 10.1021/acs.jctc.8b00687 | 2018 |
Epoxide Hydrolase-TPPU | WExplore | 300 | Charmm36 + CGenFF | 2.4 · 10–2 [3.6 · 10–3 s−1, 4.4 · 10–2 s−1] | 1.5 · 10–3 | 6 | 10.1021/jacs.7b08572 | 2018 |
p38 kinase/1-(3-(tert-butyl)-1- (p-tolyl)-1H-pyrazol-5-yl)urea | In-MetaD | 300 | Amber99SB-ILDN + GAFF | 0.020 ± 0.011 | 0.14 | 6.8 | 10.1021/jacs.6b12950 | 2017 |
M2 muscarinic receptor/iperoxo | FA-MetaD | 310 | Amber14SB + GAFF | (3.7 ± 0.7)·10–4 | (1.0 ± 0.2)·10–2 | 8 | 10.1021/acs.jpclett.0c00999 | 2020 |
HSP90-inhibitor | dcTMD | 300 | Amber99SB + GAFF | (1.6 ± 0.2)·10–3 | (3.4 ± 0.2)·10–2 | 5000 c | 10.1038/s41467-020-16655-1 | 2020 |
Mdm2/PMI | MSM | 300 | Amber99SB-ILDN | 0.125 [0.025, 0.66] 1.13 [0.48, 1.33] (Different rate matrix estimators) | 0.037 [0.029, 0.04] | 500 | 10.1038/s41467-017-01163-6 | 2017 |
Mdm2/p53 | MSM | 300 | Amber99SB-ILDN-NMR | 1.9·105 | 2.1 | 831 | 10.1016/j.bpj.2017.07.009 | 2017 |
SH3 Domain—1CKB | Pep-GaMD | 300 | Amber14SB | (1.45 ± 1.17)·10–3 | 8.9 · 10–3 | 3 | 10.1063/5.0021399 | 2020 |
MtKatG—Isonazid | τRAMD + extrapolation | 300 | CHARMM36 + SwissParam | (2.8 ± 3.7)·10–2 | (2.0 ± 0.3)·10–2 | — | 10.1021/acs.jpclett.1c02952 | 2021 |
The Authors in the original work considered the experimental koff at 293 K (800 ± 200 s−1), while they simulated the system at 300 K. Here we choose to put the value at the closest temperature available in experiments (303K—950 ± 200 s−1). Both the experimental values come from (Feher et al., 1996).
The experimental value has been measured at 293 K.
For dcTMD, computational time is referred to 1D Langevin simulator, and the authors says that “1 ms of simulation time at a 5 fs time step take ∼6 h of wall-clock time on a single CPU”.
The use of biased simulations can greatly reduce the sampling requirements. Wu et al., (2016) showed that by integrating unbiased MD with umbrella sampling simulation data, only 5%–10% of the unbiased data was necessary to estimate the dissociation rate of the trypsin-benzamidine complex up to statistical significance (k off = 1170s−1 [617s−1, 2120s−1]). A combination of 500 μs of unbiased MD and 1 μs of Hamiltonian replica exchange simulation was used to create an MSM model describing the binding of the oncoprotein fragment Mdm2 and a peptide inhibitor PMI. Estimates based on two different post-processing schemes yielded values of k off = 0.125 s−1 [0.025 s−1, 0.66 s−1] and k off = 1.13 s−1 [0.48 s−1, 1.33 s−1], corresponding to a 10–30-fold overestimation relative to experiments (k off = 0.037 s−1 [0.029 s−1, 0.04 s−1]) (Paul et al., 2017).
4 Path Sampling Methods
Path sampling methods focus on generating an ensemble of transition pathways between bound and unbound states. Typically, this class of methods accelerates the unbinding event by exploiting restarting strategies to favor the sampling of short trajectories in the vicinity of the transition state, which are then used to reconstruct the full unbinding process. Weighted Ensemble (WE) (Huber and Kim, 1996), milestoning (Cho et al., 2006; Elber, 2007), transition state-partial path interface sampling (TS-PPTIS) (Juraszek et al., 2013), and adaptive multilevel splitting (AMS) (Cérou and Guyader, 2007; Cérou et al., 2011) are path sampling methods that were employed in calculations of k off for ligand/protein complexes.
4.1 Weighted Ensemble Methods
4.1.1 Basic principles
A set of unbiased molecular dynamics trajectories with equivalent statistical weights are spawned in parallel from a ligand/protein complex in the ground-state configuration (Huber and Kim, 1996). The configuration space is then subdivided into bins, which the trajectories/walkers navigate through. The weighted ensemble (WE) method aims to maintain a fixed number (N) of walkers per bin. Thus, the occupancy of the bins is calculated at specific resampling intervals τint. If the number of walkers in a given bin is lower than N, one or more of the walkers are cloned, with each daughter trajectory receiving a fraction of the weight of the original. Conversely, in regions populated by a number of walkers exceeding N, two or more trajectories are merged, with the resulting trajectory inheriting the weights of its constituents (Zuckerman and Chong, 2017). This process results in a resampled trajectory space spanning the bound, intermediate and unbound states from which k off values can be obtained (Zhang et al., 2010).
Notably, the method does not require a detailed a prori definition of differentiable collective variables, and it is embarrassingly parallel. Given that the availability of Tier-0 and Tier-1 machines has grown significantly since the method was first formulated, several scalable open-source implementations have emerged. These include WExplore (Dickson and Brooks, 2014), Wepy (Lotz and Dickson, 2020), and REVO (Resampling of Ensembles by Variation Optimization) (Donyapour et al., 2019). The latter is a method featuring a novel resampling algorithm replacing bins in configurational space with a system-specific all-to-all pairwise distance matrix between walkers, thereby decreasing the correlation between trajectories. The novel concurrent adaptive sampling (CAS) algorithm (Ahn et al., 2017) builds on the traditional WE method by adaptively constructing macrostates (represented by n-dimensional Voronoi cells) while approximating the committor function of each macrostate, and clustering the macrostates according to their committor functions as the simulation progresses. This improves the efficiency of WE simulations in high-dimensional systems, by directing computational power to sampling portions of configuration space that are closer to the “product” configuration.
4.1.2 Applications
The k off of the trypsin-benzamidine complex as calculated by WExplore (5560 s−1) (Dickson and Lotz, 2017) overestimated by one order of magnitude the experimental value (600 s−1) (Guillian and Thusias, 1970). This value was calculated from five independent WExplore runs, corresponding to an aggregate simulation time of 4.1 μs. Using clustering-based confirmation space network analysis techniques (Dickson and Brooks, 2013), three distinct ligand exit pathways were unearthed from the trajectories. The trypsin-benzamidine system was later investigated again with REVO (Donyapour et al., 2019). Based on five independent REVO runs, giving a total of 8.75 μs, a k off of 2660 s−1 was predicted—a minor improvement on WExplore, but an overestimation nonetheless. WExplore was also employed to estimate the dissociation rate of the TPPU inhibitor from soluble epoxide hydrolase. The calculated k off (2.4 ⋅ 10–2 s−1 [3.6 ⋅ 10–3 s−1, 4.4 ⋅ 10–2 s−1]) was one order of magnitude greater than the experimental value of 3.6 ⋅ 10–3 s−1. (Lotz and Dickson, 2018), and required 6 μs of simulation time to compute. However, the reason for the systematic overestimations of k off is not explicitly addressed. REVO was recently employed (Dixon et al., 2021) to quantify k off values for five distinct bound poses of the PK-11195 radioligand in complex with TSPO (see Table 1), using a cumulative 5.18 μs of simulation time per pose. The calculated values for the poses spanned five orders of magnitude, and the pose with the most favorable docking score (pose D1, k off = 6.4 × 10–5 s−1) exhibited the closest agreement with the experimental value (4.9 × 10–4 s−1) out of all the docked poses. All the of the studies described here made use of the CHARMM36 (Best et al., 2012) and CGenFF (Vanommeslaeghe et al., 2011) force fields. At present, the CAS method described in Section 4.1.1 has been successfully applied to host-guest systems only (Ahn et al., 2020).
4.2 Milestoning
4.2.1 Basic principles
Here, the configuration space is treated as a coarse mesh characterized by slowly relaxing variables, such as native contacts and/or distances between chemical groups that describe the ligand unbinding process (Cho et al., 2006; Elber, 2007). The mesh must be coarse enough for distinct long-lived metastable states to emerge, but fine enough to ensure that transitions between the interfaces between the mesh’s cells or “milestones” are accessible in MD simulations. Equilibrium configurations for each milestone are usually generated with “pulling” SMD simulations, or with a series of MD simulations in which the diffusing group is harmonically restrained to the milestone surface. Afterward, a set of trajectories is spawned from each milestone, and whenever a trajectory reaches a new neighboring milestone, it is terminated. In practice, the criteria for termination of trajectories vary depending on the implementation. The lifetime and flux (i.e., number of trajectories passing through the milestone per unit time) associated with each milestone may be used to compute the ligand residence time (Elber, 2020).
Practical implementations of milestoning in ligand unbinding studies fall into two categories: 1) The Simulation Enabled Estimation of Kinetic Rates (SEEKR) (Votapka et al., 2017) approach, which exploits milestoning theory in a multiscale framework based on MD and Brownian Dynamics (BD) simulations (Luty et al., 1993). The milestones are nested spherical shells surrounding the binding pocket. Transitions between milestones close to the binding pocket are simulated using all-atom MD. Meanwhile, transitions between the more diffuse milestones further away are described by cheaper BD simulations—where fast sampling of rigid body interactions is more important than detailed sampling of ligand conformations. An updated implementation of SEEKR, named MMVT SEEKR, has been subsequently proposed (Jagger et al., 2020): it circumvents the need to compute the equilibrium distribution for all the milestones, reducing the computational time needed to compute kinetics constants. 2) The recently formulated weighted ensemble milestoning (WEM) methods combine milestoning theory with WE methods. Here, the configurational space between the milestones is split into bins, and WE simulations are run in between milestones to achieve faster convergence (Ray and Andricioaei, 2020).
4.2.2 Applications
All applications to kinetics of biological systems so far are based on AMBER14SB (Maier et al., 2015) and GAFF (Wang et al., 2004) force fields and applied to the trypsin-benzamidine complex. SEEKR yielded a k off of 83 ± 14 s−1 for the trypsin-benzamidine system using 19 μs of aggregate MD and ten spherical milestones. These results underestimate the experimental value (600 ± 300 s−1) (Guillian and Thusias, 1970). MMVT SEEKR improved the k off estimate (174 ± 9 s−1), with only a quarter of the aggregate simulation time (4.4 μs) used in the prior SEEKR study. WEM (Ray and Andricioaei, 2020) gave a further improvement k off = 791 ± 197 s−1, using a mere 0.5 μs of simulation time (Ray et al., 2022).
4.3 Transition State-Partial Path Transition Interface Sampling
4.3.1 Basic principles
In transition state-partial path transition interface sampling (TS-PPTIS) (Juraszek et al., 2013) an initial metadynamics calculation is performed to determine the transition state and the free energy barrier along a given CV. Then, the transmission coefficient is estimated, similarly to the PPTIS method (Van Erp et al., 2003; Moroni et al., 2004) by foliating the barrier region along the CV with interfaces and sampling short trajectories spanning three consecutive interfaces. These trajectories are sampled using transition path sampling (Pratt, 1986; Dellago et al., 1998). Under the assumptions that the dynamics in the barrier region is diffusive and there are no memory effects for travelled distances beyond two interfaces, the kinetic rates are independent of the CV.
4.3.2 Applications
TS-PPTIS was used to compute the k off of the imatinib-Src kinase complex (Morando et al., 2016). The calculation used 5 CVs: 2 path collective variables (Branduardi et al., 2007), a CV counting the number of water molecules interacting with the ligand and the binding cavity, and two distances between key residues of Src characterizing the motion of the kinase A-loop. Using AMBER99SB*-ILDN and GAFF, the authors computed a value of k off = 0.0114 s−1 [0.001 s−1, 0.139 s−1], which is slow (but within statistical significance) compared to experiments (k off = 0.11 ± 0.08 s−1). In a separate work (Haldar et al., 2018), the authors refined the prediction by computing a free energy correction from the MM to a hybrid quantum mechanics/molecular mechanics Hamiltonian using a replica exchange thermodynamic integration scheme (Woods et al., 2003) and Metropolis-Hastings Monte Carlo sampling (Woods et al., 2008). This correction does not account for dynamical effects but only for changes in the free energy. The computed correction to k off was small but consistent with faster dissociation dynamics obtaining a corrected value of k off = 0.026 s−1.
4.4 Adaptive Multilevel Splitting
4.4.1 Basic principles
Similarly to WE, adaptive multilevel splitting (AMS) (Cérou and Guyader, 2007; Cérou et al., 2011) relies on a set of trajectories that are systematically cloned or killed. However, AMS does not require bins. Instead, the algorithm is initialized by generating a set of “loop” trajectories starting and ending in the bound state. At each iteration, the replica that travelled the least distance d from the bound state (measured through a CV) is killed, and a new loop is created by restarting a simulation from a point at the same distance d previously visited by one of the remaining replicas. This is repeated until all loops travelled a distance above a threshold value (defining the unbound state) before returning to the bound state. The dissociation rate is then estimated from this collection of trajectories.
4.4.2 Applications
AMS was used to calculate the dissociation rate of trypsin-benzamidine using the CHARMM36 force field (Best et al., 2012) for trypsin and CGenFF (Vanommeslaeghe et al., 2011) for the ligand (Teo et al., 2016). As the CV, the authors used the distance between the center of mass of benzamidine and the alpha carbons of the amino acids close to the binding site. A suitable value for the threshold value of the CV was obtained through a steered MD simulation. Furthermore, 130 ns unbiased MD simulation was run to estimate the average time of a looping trajectory under the assumption that the short loops thus sampled represented the large majority of loops and thus dominated the average loop duration. In total, 2.3 μs of simulations were used to obtain a k off = 260 s−1 ± 240 s−1, in good agreement with experimental measurements.
5 Limitations Associated With Force Fields
Table 1 summarizes the k off predictions of various ligand/protein systems obtained using the methods discussed in previous sections. For completeness, we also report the temperature, total simulation time, and force field used. In about one-third of the cases, spanning all different classes of methodologies and force fields, the theoretical predictions are in the same order of magnitude as the experimental values, and in a few cases (shown in boldface in Table 1) reproduce them within statistical error. In most cases, however, calculated values show discrepancies from 1 to 2 orders of magnitude, regardless of the method and force field. Similarly, the only predictive study reported so far (Paul et al., 2017) reports values with an error of 1–2 orders of magnitude (albeit with large statistical errors) relative to experimental data performed afterwards. 5 All these results, taken together, lead us to suggest that regular force fields may be, at times, not accurate enough to predict k off values.
Determining the source of the observed errors is a difficult task without dedicated studies as the accuracy of the predictions depends on methodological aspects, sampling accuracy, and the potential energy function, which are subject to mutual cancellation (or amplification) of error. In this and the next section, we discuss the literature focusing on the effect of the potential.
5.1 Force Field Dependence of the Results
The published data indicate that careful parametrization of the force fields is essential to obtain k off predictions. Comparison between the results obtained from brute force MD calculations on a set of ligands binding to a β-cyclodextrin (βCD) host showed that k off predictions parametrizing βCD with the Q4MD force field (Cézard et al., 2011) were consistently more accurate (within one order of magnitude of experimental values) than the GAFF-based (Wang et al., 2004) estimates (Tang and Chang, 2018). On the other hand, the k on estimates were consistently better for the GAFF model, which points to the difficulty of obtaining transferable potentials. In the case of benzene unbinding from L99A T4 lysozyme, infrequent MetaD simulations using CHARMM22 (MacKerell et al., 1998; MacKerell Jr. et al., 2004) yielded a significantly underestimated k off in the range of 4–10 s−1 (Wang et al., 2018), while the same method combined with CHARMM36 (Best et al., 2012) produced a k off (270 ± 100 s−1) (Mondal et al., 2018) considerably closer to the experimental value of 950 ± 20 s−1 (Feher et al., 1996). Although different CVs were used in these two works (see Section 2.4.2), the effect of the force field cannot be ruled out. Indeed, the two force fields differ only in a few dihedral potential terms (Best et al., 2012) that control the rigidity of secondary structures, and in particular two helices of T4 which control benzene’s access to the binding pocket. Finally, we mention here the work of (Vitalini et al., 2015), where it was shown that slow relaxation timescales of two small peptides using five protein force fields (AMBER99SB-ILDN (Lindorff-Larsen et al., 2010), AMBERff03 (Duan et al., 2003), OPLS-AA/L (Kaminski et al., 2001), CHARMM27 (MacKerell et al., 2000), and GROMOS43a1 (Daura et al., 1998)) differ up to two orders of magnitude. Given the importance of slow protein conformational changes in unbinding kinetics (Plattner and Noé, 2015), this result further highlights the role of force fields for accurate rate calculations.
5.2 Polarization and Charge Transfer Effects
Traditional force fields describe electrostatics using fixed point charges. This representation is extremely efficient and works remarkably well, even in the case of systems with high electric fields (Mironenko et al., 2021). However, such a scheme cannot adapt to changes in the electrostatic environment observed during ligand unbinding. Recently, some of us (Capelli et al., 2020) found that electrostatic effects contribute significantly to the force field misrepresentation of protein-ligand interactions at the transition state of the M2-iperoxo complex. Furthermore, the work of Haldar and coworkers (Haldar et al., 2018) showed that accounting for changes in charge distribution resulted in free energy corrections ranging from 1.9 to 4.7 kcal/mol as the ligand progressed from the hydrophobic binding pocket to the solvated state. Metalloenzymes (representing 40%–50% of all proteins in the PDB database (Chen et al., 2019)) and highly charged protein-ligand systems are also quite challenging to describe with traditional force fields (Li and Merz, 2017). Indeed, for the latter systems, FF-based binding free energy calculations resulted in significant systematic errors (Rocklin et al., 2013). Overall, these results show that going beyond standard fixed-charged models is in many cases desirable to improve accuracy.
6 Perspectives: From Polarizable Force Fields to QM/MM Calculations Towards the Exascale
Force fields have been overwhelmingly successful in predicting equilibrium properties such as free energies of binding (Karplus and McCammon, 2002; Wang et al., 2015; Robustelli et al., 2022). Indeed, force fields are traditionally fitted to reproduce equilibrium experimental measurements (ensemble averages) and geometries obtained with quantum mechanical methods. As a result, their performance is expected to peak in the regions near the free energy minima (e.g., the bound state) rather than near the kinetically relevant transition states, where small errors are exponentially amplified in k off predictions. 6 After observing discrepancies of two orders of magnitude in the kinetic predictions of several force fields, Vitalini and coworkers (Vitalini et al., 2015) suggested that kinetic information should be included in the fitting process. In general, designing new parametrization strategies for force fields is still a very active area of research (He et al., 2020; Giannos et al., 2021; Qiu et al., 2021). This is not surprising, given the issues discussed in Section 5. For example, methods to include polarization effects within a fixed-charge scheme (Kelly and Smith, 2020) and multisite models for transition metal ions have been developed (Li and Merz, 2017).
A different direction pursued by the modeling community is instead to use potential energy functions that go beyond the biomolecular force fields’ simple representation of electrostatics (e.g., polarizable force fields, hybrid quantum mechanics/molecular mechanics (QM/MM) calculations, machine learning potentials). Without any claim of being comprehensive, here we provide a brief perspective on the role of these methods in the upcoming era of exascale computing.
6.1 Polarizable Force Fields
Polarizable force fields for biomolecules (Jing et al., 2019) including AMBER ff02pol (Wang Z. X. et al., 2006), AMOEBA (Ponder et al., 2010) CHARMM Drude (Baker et al., 2010), CHARMM-FQ (Patel and Brooks, 2003; Patel and Brooks, 2004), SIBFA (Piquemal et al., 2007), and ABEEMσπ (Liu et al., 2017) aim at providing an empirical description electronic polarizability. Simulations based on these potentials could dramatically improve the modeling of transition states in cases where electronic polarization and charge transfer may be linked to non-trivial rearrangements of hydrogen bonds and hydrophobic interactions (Schmidtke et al., 2011; Schiebel et al., 2018). Although polarizable force fields have recently shown excellent accuracy in prospective predictions of binding affinities in model systems (Amezcua et al., 2022), to the best of our knowledge, they have not been used for protein-ligand k off predictions yet. Notably, in a very recent paper (Yue et al., 2022), it was shown how using a polarizable force field improved the accuracy of the predictions of anion permeation rates in fluoride channels compared to predictions based on standard fixed charge schemes, highlighting the necessity of using polarizable models for treating such processes. Although this is not a ligand/protein system, this work further showcases the limitations of conventional force fields in treating electrostatic interactions as well as the potential of polarizable models.
6.2 QM/MM Simulations
DFT-based QM/MM simulations treat a small region of interest (in our case this could be a ligand and the protein residues interacting with it) at the DFT level, while the overall computational cost is balanced by MM treatment of other regions (Kulik, 2018). The form of the potential energy is a hybrid model between classical mechanics and quantum chemistry:
(3) |
where denotes the interaction between atom groups assigned to the QM region and MM region. DFT-based QM/MM simulations include both electronic polarizability and charge transfer effects (Blumberger, 2008; Capelli et al., 2020), and they address the problem of transferability, as they do not rely on optimizations against predefined training data sets. These approaches can tackle important biomedicine problems such as the study of transition-metal-based drugs binding to proteins (Calandrini et al., 2015) or the description of enzymatic reactions. (Carloni et al., 2002; Liao and Thiel, 2013; Roston et al., 2016; Caldararu et al., 2018; Kulik, 2018; Piniello et al., 2021) However, these simulations are orders of magnitude more expensive than any of the potentials described so far, and hence achieving high statistical accuracy with such an approach is obviously extremely challenging.
6.2.1 Parallel Computing in DFT-Based QM/MM
Modern supercomputers are currently breaching the exascale limit in the United States (Schneider, 2022), Japan, and China. 7 Exascale calculations however remain one of the major challenges in molecular simulations (Hospital et al., 2015; Páll et al., 2015). Recent advances in massively scalable QM/MM codes, such as that developed in Juelich in collaboration with European universities (Olsen et al., 2019; Bolnykh et al., 2020a) (see Supplementary Material S7) and their successful applications to predict free energy landscapes associated with biological processes (Bolnykh et al., 2020a; Chiariello et al., 2020) brings us to suggest that in a not-too-far future QM/MM calculations may exploit the unprecedented power of exascale computing for direct MD simulations of ligand (un)binding (Bolnykh et al., 2020b, Bolnykh et al., 2021).
6.2.2 Machine Learning in QM/MM
Neural network models of the potential energy function have emerged as a promising route to obtaining near-DFT accuracies (Unke et al., 2021; Kocer et al., 2022) at a computational cost only 1–2 orders of magnitude slower than force fields. Applications to the kinetics of chemical reactions have been published (Stocker et al., 2020; Yang et al., 2022) and in principle, they could be used to model DFT-based QM/MM predictions of ligand poses during the unbinding process. However, ML potentials are currently still limited to small molecule applications and robust solutions to model long-range interactions have yet to emerge (Yue et al., 2021). The advent of exascale computing could dramatically expand the domain of applicability of such approaches (Lu et al., 2021). Moreover, several approaches to solve these issues have been proposed based on hybrid machine learning/molecular mechanics models (Shen and Yang, 2018; Rufa et al., 2020; Böselt et al., 2021; Gastegger et al., 2021) (see Supplementary Material S8 for details).
7 Conclusion
We have reviewed an array of rather diverse methods able to predict unbinding kinetics constants using atomistic representations of the biomolecules involved. These techniques have shown tremendous progress in the last years: considering trypsin-benzamidine as a benchmark system (as seen in Table 1), we start from 2–3 orders of magnitude in k off error in the pioneering MSMs of De Fabritiis and co-workers (Buch et al., 2011) to an error of less than 1 order of magnitude in some of the most recent calculations (Plattner and Noé, 2015; Votapka et al., 2017; Brotzakis et al., 2019; Wolf et al., 2020). Despite these impressive methodological advances, the domain of applicability and accuracy appears to be still limited by current force fields. Better parametrization and polarizable force fields (Lin and MacKerell, 2019) promise to improve the quality of the potential energy model at a reasonable cost at a reasonable computational cost (Lemkul et al., 2016). Another possibility is the use of massively parallel DFT-QM/MM complemented by ML techniques, which include electronic polarizability as well as charge transfer. This approach could address the issue of transferability of current biomolecular force fields. However, the accuracy of these approaches is yet to be established.
Traditionally, computational drug discovery has used a combination of methods such as docking (Ferreira et al., 2015), quantitative structure-activity relationship (QSAR) modeling (Dossetter et al., 2013), free-energy methods (Cournia et al., 2017), and (recently) ML-based approaches (Zhao et al., 2020) to improve the binding affinity of a compound during lead optimization. Computer-aided ligand design campaigns could enormously profit from the design of so-called transition state analogues which, in the case of enzyme inhibitors, have been correlated with release rates that are orders of magnitude slower than product release (Schramm, 2013; Schramm 2015; Svensson et al., 2015). We hope that approaches beyond the use of standard force fields, such as those discussed here, will lead in a not-too-distant future to the accurate description of the energetics and structural determinants of the unbinding transition states, giving an unprecedented boost to the discovery of promising new small molecules and the optimization of known drugs.
Acknowledgments
The authors are indebted to Prof. Michele Parrinello for many discussions on the topic of kinetics of ligand binding to proteins.
Footnotes
These techniques include, among others, scaled MD (Sinko et al., 2013; Bernetti et al., 2018), steered MD (Paci and Karplus, 2000; Potterton et al., 2019; Spiriti and Wong, 2021), targeted MD (Schlitter et al., 1994; Wolf et al., 2019), GAMBES (Debnath and Parrinello, 2020) path-reweighting methods (Chodera et al., 2011; Donati et al., 2017; Kieninger and Keller, 2021) metadynamics of paths (Mandelli et al., 2020) and many transition path sampling-derived methods (Pratt, 1986; Dellago et al., 1998; Van Erp et al., 2003). A brief review of some of these methods (namely scaled MD, targeted MD and GAMBES) is given in the supplementary material.
A Kramers’ rate theory correction has been developed for scaled MD as well but it has not been applied to the calculation of full dissociation rates (see Supplementary Material S3.3).
Each of these steps require careful considerations and hyperparameter tuning, and we refer the reader to the excellent reviews on the technical aspects of the method(Husic and Pande, 2018; Suárez et al., 2021). Deep learning techniques (e.g., VAMPnets) (Mardt et al., 2018) may assist the optimization of parameters greatly, although this has not been demonstrated so far for ligand unbinding studies.
i.e., the probability of observing the system in a state y after the lag time given that it was in state x does not depend on the states of the system before x.
All the other studies in Table 1 are instead retrospective, and large-scale benchmarks in prospective settings (which are now common for binding affinity calculations) (Parks et al., 2020; Schindler et al., 2020) are missing.
The k off values depend exponentially on the height of the dissociation free energy barrier, so even small inaccuracies in the potential energy may impact dramatically kinetics calculations.
According to the Top500 list (https://www.top500.org/), which ranks computers based on their performance on the HPLinpack benchmark (Dongarra et al., 2003), currently there are no machines that have exceeded the exascale limit. The Fugaku supercomputer in Japan showed performances above one EFlop/s, but on a different benchmark (Kudo et al., 2020). In China, one or two exascale supercomputers might be already operating(Ma et al., 2022; Schneider, 2022).
Author Contributions
KA is the first author. AR and RC made equal contributions as second authors. DM is third author, WL is the fourth. Prof. PC is the PI and the last author.
Funding
AR, PC, and DM acknowledge support from the Helmholtz European Partnering program (“Innovative high-performance computing approaches for molecular neuromedicine”). KA and PC acknowledge funding from the Human Brain Project (EU Horizon 2020). W.L. appreciates the National Natural Science Foundation of China No. 21505134.
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary Material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fmolb.2022.899805/full#supplementary-material
References
- Ahn S.-H., Grate J. W., Darve E. F. (2017). Efficiently Sampling Conformations and Pathways Using the Concurrent Adaptive Sampling (CAS) Algorithm. J. Chem. Phys. 147, 074115. 10.1063/1.4999097 [DOI] [PubMed] [Google Scholar]
- Ahn S.-H., Jagger B. R., Amaro R. E. (2020). Ranking of Ligand Binding Kinetics Using a Weighted Ensemble Approach and Comparison with a Multiscale Milestoning Approach. J. Chem. Inf. Model. 60, 5340–5352. 10.1021/acs.jcim.9b00968 [DOI] [PubMed] [Google Scholar]
- Amaral M., Kokh D. B., Bomke J., Wegener A., Buchstaller H. P., Eggenweiler H. M., et al. (2017). Protein Conformational Flexibility Modulates Kinetics and Thermodynamics of Drug Binding. Nat. Commun. 8, 2276. 10.1038/s41467-017-02258-w [DOI] [PMC free article] [PubMed] [Google Scholar]
- Amezcua M., Setiadi J., Ge Y., Mobley D. L. (2022). An Overview of the SAMPL8 Host-Guest Binding Challenge. ChemRxiv, 1–42. 10.26434/chemrxiv-2022-lwd0h [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ansari N., Rizzi V., Parrinello M. (2022). Water Regulates the Residence Time of Benzamidine in Trypsin. ArXiv, 1–16. Available at: http://arxiv.org/abs/2204.05572 . (Accessed April 16, 2022). [DOI] [PMC free article] [PubMed]
- Baker C. M., Lopes P. E. M., Zhu X., Roux B., MacKerell A. D. (2010). Accurate Calculation of Hydration Free Energies Using Pair-specific Lennard-Jones Parameters in the CHARMM Drude Polarizable Force Field. J. Chem. Theory Comput. 6, 1181–1198. 10.1021/ct9005773 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Barducci A., Bussi G., Parrinello M. (2008). Well-tempered Metadynamics: A Smoothly Converging and Tunable Free-Energy Method. Phys. Rev. Lett. 100, 1–4. 10.1103/PhysRevLett.100.020603 [DOI] [PubMed] [Google Scholar]
- Bartels C., Karplus M. (1997). Multidimensional Adaptive Umbrella Sampling: Applications to Main Chain and Side Chain Peptide Conformations. J. Comput. Chem. 18, 1450–1462. [DOI] [Google Scholar]
- Bernetti M., Rosini E., Mollica L., Masetti M., Pollegioni L., Recanatini M., et al. (2018). Binding Residence Time through Scaled Molecular Dynamics: A Prospective Application to hDAAO Inhibitors. J. Chem. Inf. Model. 58, 2255–2265. 10.1021/acs.jcim.8b00518 [DOI] [PubMed] [Google Scholar]
- Best R. B., Hummer G. (2009). Optimized Molecular Dynamics Force Fields Applied to the Helix−Coil Transition of Polypeptides. J. Phys. Chem. B 113, 9004–9015. 10.1021/jp901540t [DOI] [PMC free article] [PubMed] [Google Scholar]
- Best R. B., Zhu X., Shim J., Lopes P. E. M., Mittal J., Feig M., et al. (2012). Optimization of the Additive CHARMM All-Atom Protein Force Field Targeting Improved Sampling of the Backbone ϕ, ψ and Side-Chain χ1 and χ2 Dihedral Angles. J. Chem. Theory Comput. 8, 3257–3273. 10.1021/ct300400x [DOI] [PMC free article] [PubMed] [Google Scholar]
- Blumberger J. (2008). Free Energies for Biological Electron Transfer from QM/MM Calculation: Method, Application and Critical Assessment. Phys. Chem. Chem. Phys. 10, 5651–5667. 10.1039/B807444E [DOI] [PubMed] [Google Scholar]
- Bolnykh V., Olsen J. M. H., Meloni S., Bircher M. P., Ippoliti E., Carloni P., et al. (2020a). MiMiC: Multiscale Modeling in Computational Chemistry. Front. Mol. Biosci. 7, 1–4. 10.3389/fmolb.2020.00045 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bolnykh V., Rossetti G., Rothlisberger U., Carloni P. (2021). Expanding the Boundaries of Ligand–Target Modeling by Exascale Calculations. Wiley Interdiscip. Rev. Comput. Mol. Sci. 11. 10.1002/wcms.1535 [DOI] [Google Scholar]
- Bolnykh V., Rothlisberger U., Carloni P. (2020b). Biomolecular Simulation: A Perspective from High Performance Computing. Isr. J. Chem. 60, 694–704. 10.1002/ijch.202000022 [DOI] [Google Scholar]
- Böselt L., Thürlemann M., Riniker S. (2021). Machine Learning in QM/MM Molecular Dynamics Simulations of Condensed-phase Systems. J. Chem. Theory Comput. 17, 2641–2658. 10.1021/acs.jctc.0c01112 [DOI] [PubMed] [Google Scholar]
- Bowman G. R., Ensign D. L., Pande V. S. (2010). Enhanced Modeling via Network Theory: Adaptive Sampling of Markov State Models. J. Chem. Theory Comput. 6, 787–794. 10.1021/ct900620b [DOI] [PMC free article] [PubMed] [Google Scholar]
- Branduardi D., Gervasio F. L., Parrinello M. (2007). From A to B in Free Energy Space. J. Chem. Phys. 126, 054103. 10.1063/1.2432340 [DOI] [PubMed] [Google Scholar]
- Brotzakis Z. F., Limongelli V., Parrinello M. (2019). Accelerating the Calculation of Protein-Ligand Binding Free Energy and Residence Times Using Dynamically Optimized Collective Variables. J. Chem. Theory Comput. 15, 743–750. 10.1021/acs.jctc.8b00934 [DOI] [PubMed] [Google Scholar]
- Bruce N. J., Ganotra G. K., Kokh D. B., Sadiq S. K., Wade R. C. (2018). New Approaches for Computing Ligand-Receptor Binding Kinetics. Curr. Opin. Struct. Biol. 49, 1–10. 10.1016/j.sbi.2017.10.001 [DOI] [PubMed] [Google Scholar]
- Buch I., Giorgino T., De Fabritiis G. (2011). Complete Reconstruction of an Enzyme-Inhibitor Binding Process by Molecular Dynamics Simulations. Proc. Natl. Acad. Sci. U.S.A. 108, 10184–10189. 10.1073/pnas.1103547108 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bussi G., Laio A. (2020). Using Metadynamics to Explore Complex Free-Energy Landscapes. Nat. Rev. Phys. 2, 200–212. 10.1038/s42254-020-0153-0 [DOI] [Google Scholar]
- Calandrini V., Rossetti G., Arnesano F., Natile G., Carloni P. (2015). Computational Metallomics of the Anticancer Drug Cisplatin. J. Inorg. Biochem. 153, 231–238. 10.1016/j.jinorgbio.2015.10.001 [DOI] [PubMed] [Google Scholar]
- Caldararu O., Feldt M., Cioloboc D., Van Severen M.-C., Starke K., Mata R. A., et al. (2018). QM/MM Study of the Reaction Mechanism of Sulfite Oxidase. Sci. Rep. 8, 1–15. 10.1038/s41598-018-22751-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Capelli R., Lyu W., Bolnykh V., Meloni S., Olsen J. M. H., Rothlisberger U., et al. (2020). Accuracy of Molecular Simulation-Based Predictions of Koff Values: A Metadynamics Study. J. Phys. Chem. Lett. 11, 6373–6381. 10.1021/acs.jpclett.0c00999 [DOI] [PubMed] [Google Scholar]
- Carloni P., Rothlisberger U., Parrinello M. (2002). The Role and Perspective of Ab Initio Molecular Dynamics in the Study of Biological Systems. Acc. Chem. Res. 35, 455–464. 10.1021/ar010018u [DOI] [PubMed] [Google Scholar]
- Casasnovas R., Limongelli V., Tiwary P., Carloni P., Parrinello M. (2017). Unbinding Kinetics of a P38 MAP Kinase Type II Inhibitor from Metadynamics Simulations. J. Am. Chem. Soc. 139, 4780–4788. 10.1021/jacs.6b12950 [DOI] [PubMed] [Google Scholar]
- Cérou F., Guyader A. (2007). Adaptive Multilevel Splitting for Rare Event Analysis. Stoch. Analysis Appl. 25, 417–443. 10.1080/07362990601139628 [DOI] [Google Scholar]
- Cérou F., Guyader A., Lelièvre T., Pommier D. (2011). A Multiple Replica Approach to Simulate Reactive Trajectories. J. Chem. Phys. 134, 054108. 10.1063/1.3518708 [DOI] [PubMed] [Google Scholar]
- Cézard C., Trivelli X., Aubry F., Djedaïni-Pilard F., Dupradeau F.-Y. (2011). Molecular Dynamics Studies of Native and Substituted Cyclodextrins in Different Media: 1. Charge Derivation and Force Field Performances. Phys. Chem. Chem. Phys. 13, 15103–15121. 10.1039/C1CP20854C [DOI] [PubMed] [Google Scholar]
- Chen A. Y., Adamek R. N., Dick B. L., Credille C. V., Morrison C. N., Cohen S. M. (2019). Targeting Metalloenzymes for Therapeutic Intervention. Chem. Rev. 119, 1323–1455. 10.1021/acs.chemrev.8b00201 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chiariello M. G., Bolnykh V., Ippoliti E., Meloni S., Olsen J. M. H., Beck T., et al. (2020). Molecular Basis of CLC Antiporter Inhibition by Fluoride. J. Am. Chem. Soc. 142, 7254–7258. 10.1021/jacs.9b13588 [DOI] [PubMed] [Google Scholar]
- Cho S. S., Levy Y., Wolynes P. G. (2006). P versus Q : Structural Reaction Coordinates Capture Protein Folding on Smooth Landscapes. Proc. Natl. Acad. Sci. U.S.A. 103, 586–591. 10.1073/pnas.0509768103 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chodera J. D., Swope W. C., Noé F., Prinz J.-H., Shirts M. R., Pande V. S. (2011). Dynamical Reweighting: Improved Estimates of Dynamical Properties from Simulations at Multiple Temperatures. J. Chem. Phys. 134, 244107. 10.1063/1.3592152 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chong L. T., Saglam A. S., Zuckerman D. M. (2017). Path-sampling Strategies for Simulating Rare Events in Biomolecular Systems. Curr. Opin. Struct. Biol. 43, 88–94. 10.1016/j.sbi.2016.11.019 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Copeland R. A. (2021). Evolution of the Drug-Target Residence Time Model. Expert Opin. Drug Discov. 16, 1441–1451. 10.1080/17460441.2021.1948997 [DOI] [PubMed] [Google Scholar]
- Copeland R. A., Pompliano D. L., Meek T. D. (2006). Drug-target Residence Time and its Implications for Lead Optimization. Nat. Rev. Drug Discov. 5, 730–739. 10.1038/nrd2082 [DOI] [PubMed] [Google Scholar]
- Cournia Z., Allen B., Sherman W. (2017). Relative Binding Free Energy Calculations in Drug Discovery: Recent Advances and Practical Considerations. J. Chem. Inf. Model. 57, 2911–2937. 10.1021/acs.jcim.7b00564 [DOI] [PubMed] [Google Scholar]
- Crommelin D., Vanden-Eijnden E. (2009). Data-Based Inference of Generators for Markov Jump Processes Using Convex Optimization. Multiscale Model. Simul. 7, 1751–1778. 10.1137/080735977 [DOI] [Google Scholar]
- Dama J. F., Parrinello M., Voth G. A. (2014). Well-Tempered Metadynamics Converges Asymptotically. Phys. Rev. Lett. 112, 240602. 10.1103/PhysRevLett.112.240602 [DOI] [PubMed] [Google Scholar]
- Daura X., Mark A. E., Van Gunsteren W. F. (1998). Parametrization of Aliphatic CHn United Atoms of GROMOS96 Force Field. J. Comput. Chem. 19, 535–547. [DOI] [Google Scholar]
- De Vivo M., Masetti M., Bottegoni G., Cavalli A. (2016). Role of Molecular Dynamics and Related Methods in Drug Discovery. J. Med. Chem. 59, 4035–4061. 10.1021/acs.jmedchem.5b01684 [DOI] [PubMed] [Google Scholar]
- de Witte W. E. A., Danhof M., van der Graaf P. H., de Lange E. C. M. (2018). The Implications of Target Saturation for the Use of Drug-Target Residence Time. Nat. Rev. Drug Discov. 18, 84. 10.1038/nrd.2018.234 [DOI] [PubMed] [Google Scholar]
- Debnath J., Parrinello M. (2020). Gaussian Mixture-Based Enhanced Sampling for Statics and Dynamics. J. Phys. Chem. Lett. 11, 5076–5080. 10.1021/acs.jpclett.0c01125 [DOI] [PubMed] [Google Scholar]
- Dellago C., Bolhuis P. G., Csajka F. S., Chandler D. (1998). Transition Path Sampling and the Calculation of Rate Constants. J. Chem. Phys. 108, 1964–1977. 10.1063/1.475562 [DOI] [Google Scholar]
- Dickson A., Brooks C. L. (2013). Native States of Fast-Folding Proteins Are Kinetic Traps. J. Am. Chem. Soc. 135, 4729–4734. 10.1021/ja311077u [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dickson A., Brooks C. L. (2014). WExplore: Hierarchical Exploration of High-Dimensional Spaces Using the Weighted Ensemble Algorithm. J. Phys. Chem. B 118, 3532–3542. 10.1021/jp411479c.WExplore [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dickson A., Lotz S. D. (2017). Multiple Ligand Unbinding Pathways and Ligand-Induced Destabilization Revealed by WExplore. Biophysical J. 112, 620–629. 10.1016/j.bpj.2017.01.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dixon T., Uyar A., Ferguson-Miller S., Dickson A. (2021). Membrane-Mediated Ligand Unbinding of the PK-11195 Ligand from TSPO. Biophysical J. 120, 158–167. 10.1016/j.bpj.2020.11.015 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Donati L., Hartmann C., Keller B. G. (2017). Girsanov Reweighting for Path Ensembles and Markov State Models. J. Chem. Phys. 146, 244112. 10.1063/1.4989474 [DOI] [PubMed] [Google Scholar]
- Dongarra J. J., Luszczek P., Petitet A. (2003). The LINPACK Benchmark: Past, Present and Future. Concurr. Comput. Pract. Exper. 15, 803–820. 10.1002/cpe.728 [DOI] [Google Scholar]
- Donyapour N., Roussey N. M., Dickson A. (2019). REVO: Resampling of Ensembles by Variation Optimization. J. Chem. Phys. 150, 244112–12. 10.1063/1.5100521 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dossetter A. G., Griffen E. J., Leach A. G. (2013). Matched Molecular Pair Analysis in Drug Discovery. Drug Discov. Today 18, 724–731. 10.1016/j.drudis.2013.03.003 [DOI] [PubMed] [Google Scholar]
- Duan Y., Wu C., Chowdhury S., Lee M. C., Xiong G., Zhang W., et al. (2003). A Point-Charge Force Field for Molecular Mechanics Simulations of Proteins Based on Condensed-phase Quantum Mechanical Calculations. J. Comput. Chem. 24, 1999–2012. 10.1002/jcc.10349 [DOI] [PubMed] [Google Scholar]
- Durrant J. D., McCammon J. A. (2011). Molecular Dynamics Simulations and Drug Discovery. BMC Biol. 9, 71. 10.1016/B978-0-12-809633-8.20154-410.1186/1741-7007-9-71 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Elber R. (2007). A Milestoning Study of the Kinetics of an Allosteric Transition: Atomically Detailed Simulations of Deoxy Scapharca Hemoglobin. Biophysical J. 92, L85–L87. 10.1529/biophysj.106.101899 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Elber R. (2020). Milestoning: An Efficient Approach for Atomically Detailed Simulations of Kinetics in Biophysics. Annu. Rev. Biophys. 49, 69–85. 10.1146/annurev-biophys-121219-081528 [DOI] [PubMed] [Google Scholar]
- Emwas A.-H., Szczepski K., Poulson B. G., Chandra K., Mckay R. T., Dhahri M., et al. (2020). NMR as a "Gold Standard" Method in Drug Design and Discovery. Molecules 25, 4597. 10.3390/molecules25204597 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Feher V. A., Baldwin E. P., Dahlquist F. W. (1996). Access of Ligands to Cavities within the Core of a Protein Is Rapid. Nat. Struct. Mol. Biol. 3, 516–521. 10.1038/nsb0696-516 [DOI] [PubMed] [Google Scholar]
- Ferreira L., Dos Santos R., Oliva G., Andricopulo A. (2015). Molecular Docking and Structure-Based Drug Design Strategies. Molecules 20, 13384–13421. 10.3390/molecules200713384 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Folmer R. H. A. (2018). Drug Target Residence Time: a Misleading Concept. Drug Discov. Today 23, 12–16. 10.1016/j.drudis.2017.07.016 [DOI] [PubMed] [Google Scholar]
- Gastegger M., Schütt K. T., Müller K.-R. (2021). Machine Learning of Solvent Effects on Molecular Spectra and Reactions. Chem. Sci. 12, 11473–11483. 10.1039/d1sc02742e [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gelpi J., Hospital A., Goñi R., Orozco M. (2015). Molecular Dynamics Simulations: Advances and Applications. Aabc 8, 37–47. 10.2147/AABC.S70333 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Giannos T., Lešnik S., Bren U., Hodošček M., Domratcheva T., Bondar A.-N. (2021). CHARMM Force-Field Parameters for Morphine, Heroin, and Oliceridine, and Conformational Dynamics of Opioid Drugs. J. Chem. Inf. Model. 61, 3964–3977. 10.1021/acs.jcim.1c00667 [DOI] [PubMed] [Google Scholar]
- Grubmüller H. (1995). Predicting Slow Structural Transitions in Macromolecular Systems: Conformational Flooding. Phys. Rev. E 52, 2893–2906. 10.1103/physreve.52.2893 [DOI] [PubMed] [Google Scholar]
- Guillian F., Thusias D. (1970). The Use of Proflavin as an Indicator in Temperature-Jump Studies of the Binding of a Competitive Inhibitor to Trypsin. J. Am. Chem. Soc. 92 (18), 5534–5536. [DOI] [PubMed] [Google Scholar]
- Guo D., Mulder-Krieger T., IJzerman A. P., Heitman L. H. (2012). Functional Efficacy of Adenosine A2A Receptor Agonists Is Positively Correlated to Their Receptor Residence Time. Br. J. Pharmacol. 166, 1846–1859. 10.1111/j.1476-5381.2012.01897.x [DOI] [PMC free article] [PubMed] [Google Scholar]
- Haldar S., Comitani F., Saladino G., Woods C., Van Der Kamp M. W., Mulholland A. J., et al. (2018). A Multiscale Simulation Approach to Modeling Drug-Protein Binding Kinetics. J. Chem. Theory Comput. 14, 6093–6101. 10.1021/acs.jctc.8b00687 [DOI] [PubMed] [Google Scholar]
- Hänggi P., Talkner P., Borkovec M. (1990). Reaction-rate Theory: Fifty Years after Kramers. Rev. Mod. Phys. 62, 251–341. 10.1103/RevModPhys.62.251 [DOI] [Google Scholar]
- He X., Man V. H., Yang W., Lee T.-S., Wang J. (2020). A Fast and High-Quality Charge Model for the Next Generation General AMBER Force Field. J. Chem. Phys. 153, 114502. 10.1063/5.0019056 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hooft R. W. W., Van Eijck B. P., Kroon J. (1992). An Adaptive Umbrella Sampling Procedure in Conformational Analysis Using Molecular Dynamics and its Application to Glycol. J. Chem. Phys. 97, 6690–6694. 10.1063/1.463947 [DOI] [Google Scholar]
- Hornak V., Abel R., Okur A., Strockbine B., Roitberg A., Simmerling C. (2006). Comparison of Multiple Amber Force Fields and Development of Improved Protein Backbone Parameters. Proteins 65, 712–725. 10.1002/prot.21123 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Huber G. A., Kim S. (1996). Weighted-ensemble Brownian Dynamics Simulations for Protein Association Reactions. Biophysical J. 70, 97–110. 10.1016/S0006-3495(96)79552-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Huber T., Torda A. E., van Gunsteren W. F. (1994). Local Elevation: A Method for Improving the Searching Properties of Molecular Dynamics Simulation. J. Computer-Aided Mol. Des. 8, 695–708. 10.1007/BF00124016 [DOI] [PubMed] [Google Scholar]
- Husic B. E., Pande V. S. (2018). Markov State Models: From an Art to a Science. J. Am. Chem. Soc. 140, 2386–2396. 10.1021/jacs.7b12191 [DOI] [PubMed] [Google Scholar]
- Invernizzi M., Parrinello M. (2020). Rethinking Metadynamics: From Bias Potentials to Probability Distributions. J. Phys. Chem. Lett. 11, 2731–2736. 10.1021/acs.jpclett.0c00497 [DOI] [PubMed] [Google Scholar]
- Jagger B., Ojha A. A., Amaro R. (2020). Predicting Ligand Binding Kinetics Using a Markovian Milestoning with Voronoi Tessellations Multiscale Approach. ChemRxiv 16 (8), 5348–5357. 10.26434/chemrxiv.12275165.v1 [DOI] [PubMed] [Google Scholar]
- Jing Z., Liu C., Cheng S. Y., Qi R., Walker B. D., Piquemal J.-P., et al. (2019). Polarizable Force Fields for Biomolecular Simulations: Recent Advances and Applications. Annu. Rev. Biophys. 48, 371–394. 10.1146/annurev-biophys-070317-033349 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Juraszek J., Saladino G., van Erp T. S., Gervasio F. L. (2013). Efficient Numerical Reconstruction of Protein Folding Kinetics with Partial Path Sampling and Pathlike Variables. Phys. Rev. Lett. 110, 108106. 10.1103/PhysRevLett.110.108106 [DOI] [PubMed] [Google Scholar]
- Kalbfleisch J. D., Lawless J. F. (1985). The Analysis of Panel Data under a Markov Assumption. J. Am. Stat. Assoc. 80, 863–871. 10.1080/01621459.1985.10478195 [DOI] [Google Scholar]
- Kaminski G. A., Friesner R. A., Tirado-Rives J., Jorgensen W. L. (2001). Evaluation and Reparametrization of the OPLS-AA Force Field for Proteins via Comparison with Accurate Quantum Chemical Calculations on Peptides. J. Phys. Chem. B 105, 6474–6487. 10.1021/jp003919d [DOI] [Google Scholar]
- Karplus M., McCammon J. A. (2002). Molecular Dynamics Simulations of Biomolecules. Nat. Struct. Biol. 9, 646–652. 10.1299/jsmemag.116.1131_7810.1038/nsb0902-646 [DOI] [PubMed] [Google Scholar]
- Kelly B. D., Smith W. R. (2020). Alchemical Hydration Free-Energy Calculations Using Molecular Dynamics with Explicit Polarization and Induced Polarity Decoupling: An On-The-Fly Polarization Approach. J. Chem. Theory Comput. 16, 1146–1161. 10.1021/acs.jctc.9b01139 [DOI] [PubMed] [Google Scholar]
- Kieninger S., Keller B. G. (2021). Path Probability Ratios for Langevin Dynamics-Exact and Approximate. J. Chem. Phys. 154, 094102. 10.1063/5.0038408 [DOI] [PubMed] [Google Scholar]
- Kocer E., Ko T. W., Behler J. (2022). Neural Network Potentials: A Concise Overview of Methods. Annu. Rev. Phys. Chem. 73, 163–186. 10.1146/annurev-physchem-082720-034254 [DOI] [PubMed] [Google Scholar]
- Kokh D. B., Amaral M., Bomke J., Grädler U., Musil D., Buchstaller H.-P., et al. (2018). Estimation of Drug-Target Residence Times by τ-Random Acceleration Molecular Dynamics Simulations. J. Chem. Theory Comput. 14, 3859–3869. 10.1021/acs.jctc.8b00230 [DOI] [PubMed] [Google Scholar]
- Kokh D. B., Doser B., Richter S., Ormersbach F., Cheng X., Wade R. C. (2020). A Workflow for Exploring Ligand Dissociation from a Macromolecule: Efficient Random Acceleration Molecular Dynamics Simulation and Interaction Fingerprint Analysis of Ligand Trajectories. J. Chem. Phys. 153, 125102. 10.1063/5.0019088 [DOI] [PubMed] [Google Scholar]
- Kokh D. B., Kaufmann T., Kister B., Wade R. C. (2019). Machine Learning Analysis of τRAMD Trajectories to Decipher Molecular Determinants of Drug-Target Residence Times. Front. Mol. Biosci. 6, 1–17. 10.3389/fmolb.2019.00036 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kudo S., Nitadori K., Ina T., Imamura T. (2020). “Prompt Report on Exa-Scale HPL-AI Benchmark,” in 2020 IEEE International Conference on Cluster Computing (CLUSTER), Kobe, Japan. St. Louis, Missouri, USA, 418–419. 10.1109/CLUSTER49012.2020.00058 [DOI] [Google Scholar]
- Kulik H. J. (2018). Large-scale QM/MM Free Energy Simulations of Enzyme Catalysis Reveal the Influence of Charge Transfer. Phys. Chem. Chem. Phys. 20, 20650–20660. 10.1039/c8cp03871f [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kumar S., Rosenberg J. M., Bouzida D., Swendsen R. H., Kollman P. A. (1992). THE Weighted Histogram Analysis Method for Free-Energy Calculations on Biomolecules. I. The Method. J. Comput. Chem. 13, 1011–1021. 10.1002/jcc.540130812 [DOI] [Google Scholar]
- Kwarcinski F. E., Brandvold K. R., Phadke S., Beleh O. M., Johnson T. M., Meagher J. L., et al. (2016). Conformation-Selective Analogues of Dasatinib Reveal Insight into Kinase Inhibitor Binding and Selectivity. ACS Chem. Biol. 11, 1296–1304. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Laio A., Parrinello M. (2002). Escaping Free-Energy Minima. Proc. Natl. Acad. Sci. U. S. A. 99 (20), 12562–12566. 10.1073/pnas.202427399 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lee K. S. S., Yang J., Niu J., Ng C. J., Wagner K. M., Dong H., et al. (2019). Drug-Target Residence Time Affects In Vivo Target Occupancy through Multiple Pathways. ACS Cent. Sci. 5, 1614–1624. 10.1021/acscentsci.9b00770 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lemkul J. A., Huang J., Roux B., MacKerell A. D. (2016). An Empirical Polarizable Force Field Based on the Classical Drude Oscillator Model: Development History and Recent Applications. Chem. Rev. 116, 4983–5013. 10.1021/acs.chemrev.5b00505 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Li H.-J., Lai C.-T., Pan P., Yu W., Liu N., Bommineni G. R., et al. (2014). A Structural and Energetic Model for the Slow-Onset Inhibition of the mycobacterium Tuberculosis ENoyl-ACP Reductase InhA. ACS Chem. Biol. 9, 986–993. 10.1021/cb400896g [DOI] [PMC free article] [PubMed] [Google Scholar]
- Li P., Merz K. M. (2017). Metal Ion Modeling Using Classical Mechanics. Chem. Rev. 117, 1564–1686. 10.1021/acs.chemrev.6b00440 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Liao R.-Z., Thiel W. (2013). Convergence in the QM-Only and QM/MM Modeling of Enzymatic Reactions: A Case Study for Acetylene Hydratase. J. Comput. Chem. 34, a–n. 10.1002/jcc.23403 [DOI] [PubMed] [Google Scholar]
- Lin F.-Y., MacKerell A. D. (2019). Improved Modeling of Halogenated Ligand-Protein Interactions Using the Drude Polarizable and CHARMM Additive Empirical Force Fields. J. Chem. Inf. Model. 59, 215–228. 10.1021/acs.jcim.8b00616 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lindorff-Larsen K., Piana S., Palmo K., Maragakis P., Klepeis J. L., Dror R. O., et al. (2010). Improved Side-Chain Torsion Potentials for the Amber ff99SB Protein Force Field. Proteins 78, 1950–1958. 10.1002/prot.22711 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Liu C., Li Y., Han B.-Y., Gong L.-D., Lu L.-N., Yang Z.-Z., et al. (2017). Development of the ABEEMσπ Polarization Force Field for Base Pairs with Amino Acid Residue Complexes. J. Chem. Theory Comput. 13, 2098–2111. 10.1021/acs.jctc.6b01206 [DOI] [PubMed] [Google Scholar]
- Lotz S. D., Dickson A. (2018). Unbiased Molecular Dynamics of 11 Min Timescale Drug Unbinding Reveals Transition State Stabilizing Interactions. J. Am. Chem. Soc. 140, 618–628. 10.1021/jacs.7b08572 [DOI] [PubMed] [Google Scholar]
- Lotz S. D., Dickson A. (2020). Wepy: A Flexible Software Framework for Simulating Rare Events with Weighted Ensemble Resampling. ACS Omega 5, 31608–31623. 10.1021/acsomega.0c03892 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lu D., Wang H., Chen M., Lin L., Car R., E W., et al. (2021). 86 PFLOPS Deep Potential Molecular Dynamics Simulation of 100 Million Atoms with Ab Initio Accuracy. Comput. Phys. Commun. 259, 107624. 10.1016/j.cpc.2020.107624 [DOI] [Google Scholar]
- Lüdemann S. K., Lounnas V., Wade R. C. (2000). How Do Substrates Enter and Products Exit the Buried Active Site of Cytochrome P450cam? 2. Steered Molecular Dynamics and Adiabatic Mapping of Substrate Pathways 1 1Edited by J. Thornton. J. Mol. Biol. 303, 813–830. 10.1006/jmbi.2000.4155 [DOI] [PubMed] [Google Scholar]
- Luty B. A., El Amrani S., McCammon J. A. (1993). Simulation of the Bimolecular Reaction between Superoxide and Superoxide Dismutase: Synthesis of the Encounter and Reaction Steps. J. Am. Chem. Soc. 115, 11874–11877. 10.1021/ja00078a027 [DOI] [Google Scholar]
- Ma Z., He J., Qiu J., Cao H., Wang Y., Sun Z., et al. (2022). “BaGuaLu: Targeting Brain Scale Pretrained Models with over 37 Million Cores,” in ACM SIGPLAN Annual Symposium on Principles and Practice of Parallel Programming. [Google Scholar]
- MacKerell A. D., Banavali N., Foloppe N. (2000). Development and Current Status of the CHARMM Force Field for Nucleic Acids. Biopolymers 56, 257–265. [DOI] [PubMed] [Google Scholar]
- MacKerell A. D., Bashford D., Bellott M., Dunbrack R. L., Evanseck J. D., Field M. J., et al. (1998). All-atom Empirical Potential for Molecular Modeling and Dynamics Studies of Proteins. J. Phys. Chem. B 102, 3586–3616. 10.1021/jp973084f [DOI] [PubMed] [Google Scholar]
- MacKerell A. D., Jr., Feig M., Brooks C. L., III (2004). Extending the Treatment of Backbone Energetics in Protein Force Fields: Limitations of Gas-phase Quantum Mechanics in Reproducing Protein Conformational Distributions in Molecular Dynamics Simulations. J. Comput. Chem. 25, 1400–1415. 10.1002/jcc.20065 [DOI] [PubMed] [Google Scholar]
- Maier J. A., Martinez C., Kasavajhala K., Wickstrom L., Hauser K. E., Simmerling C. (2015). ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB. J. Chem. Theory Comput. 11, 3696–3713. 10.1021/acs.jctc.5b00255 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mandelli D., Hirshberg B., Parrinello M. (2020). Metadynamics of Paths. Phys. Rev. Lett. 125, 26001. 10.1103/PhysRevLett.125.026001 [DOI] [PubMed] [Google Scholar]
- Mardt A., Pasquali L., Wu H., Noé F. (2018). VAMPnets for Deep Learning of Molecular Kinetics. Nat. Commun. 9, 1–14. 10.1038/s41467-017-02388-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Maximova E., Postnikov E. B., Lavrova A. I., Farafonov V., Nerukh D. (2021). Protein-Ligand Dissociation Rate Constant from All-Atom Simulation. J. Phys. Chem. Lett. 12, 10631–10636. 10.1021/acs.jpclett.1c02952 [DOI] [PubMed] [Google Scholar]
- Mazzorana M., Shotton E. J., Hall D. R. (2020). A Comprehensive Approach to X-Ray Crystallography for Drug Discovery at a Synchrotron Facility - the Example of Diamond Light Source. Drug Discov. Today Technol. 37, 83–92. 10.1016/j.ddtec.2020.10.003 [DOI] [PubMed] [Google Scholar]
- Miao Y. (2018). Acceleration of Biomolecular Kinetics in Gaussian Accelerated Molecular Dynamics. J. Chem. Phys. 149, 072308. 10.1063/1.5024217 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Miao Y., Bhattarai A., Wang J. (2020). Ligand Gaussian Accelerated Molecular Dynamics (LiGaMD): Characterization of Ligand Binding Thermodynamics and Kinetics. J. Chem. Theory Comput. 16, 5526–5547. 10.1021/acs.jctc.0c00395 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mironenko A., Zachariae U., de Groot B. L., Kopec W. (2021). The Persistent Question of Potassium Channel Permeation Mechanisms. J. Mol. Biol. 433, 167002. 10.1016/j.jmb.2021.167002 [DOI] [PubMed] [Google Scholar]
- Mondal J., Ahalawat N., Pandit S., Kay L. E., Vallurupalli P. (2018). Atomic Resolution Mechanism of Ligand Binding to a Solvent Inaccessible Cavity in T4 Lysozyme. PLoS Comput. Biol. 14, e1006180–20. 10.1371/journal.pcbi.1006180 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Morando M. A., Saladino G., D’Amelio N., Pucheta-Martinez E., Lovera S., Lelli M., et al. (2016). Conformational Selection and Induced Fit Mechanisms in the Binding of an Anticancer Drug to the C-Src Kinase. Sci. Rep. 6, 1–9. 10.1038/srep24439 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Moroni D., Bolhuis P. G., van Erp T. S. (2004). Rate Constants for Diffusive Processes by Partial Path Sampling. J. Chem. Phys. 120, 4055–4065. 10.1063/1.1644537 [DOI] [PubMed] [Google Scholar]
- Nunes-Alves A., Kokh D. B., Wade R. C. (2020). Recent Progress in Molecular Simulation Methods for Drug Binding Kinetics. Curr. Opin. Struct. Biol. 64, 126–133. 10.1016/j.sbi.2020.06.022 [DOI] [PubMed] [Google Scholar]
- Olsen J. M. H., Bolnykh V., Meloni S., Ippoliti E., Bircher M. P., Carloni P., et al. (2019). MiMiC: A Novel Framework for Multiscale Modeling in Computational Chemistry. J. Chem. Theory Comput. 15, 3810–3823. 10.1021/acs.jctc.9b00093 [DOI] [PubMed] [Google Scholar]
- Páll S., Abraham M. J., Kutzner C., Hess B., Lindahl E. (2015). Tackling Exascale Software Challenges in Molecular Dynamics Simulations with GROMACS BT Solving Software Challenges for Exascale. in, eds. Markidis S., Laure E. (Cham: Springer International Publishing; ), 3–27. 10.1007/978-3-319-15976-8_1 [DOI] [Google Scholar]
- Paci E., Karplus M. (2000). Unfolding Proteins by External Forces and Temperature: The Importance of Topology and Energetics. Proc. Natl. Acad. Sci. U.S.A. 97, 6521–6526. 10.1073/pnas.100124597 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pan A. C., Borhani D. W., Dror R. O., Shaw D. E. (2013). Molecular Determinants of Drug-Receptor Binding Kinetics. Drug Discov. Today 18, 667–673. 10.1016/j.drudis.2013.02.007 [DOI] [PubMed] [Google Scholar]
- Pan A. C., Jacobson D., Yatsenko K., Sritharan D., Weinreich T. M., Shaw D. E. (2019). Atomic-level Characterization of Protein-Protein Association. Proc. Natl. Acad. Sci. U.S.A. 116, 4244–4249. 10.1073/pnas.1815431116 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pan A. C., Xu H., Palpant T., Shaw D. E. (2017). Quantitative Characterization of the Binding and Unbinding of Millimolar Drug Fragments with Molecular Dynamics Simulations. J. Chem. Theory Comput. 13, 3372–3377. 10.1021/acs.jctc.7b00172 [DOI] [PubMed] [Google Scholar]
- Parks C. D., Gaieb Z., Chiu M., Yang H., Shao C., Walters W. P., et al. (2020). D3R Grand Challenge 4: Blind Prediction of Protein-Ligand Poses, Affinity Rankings, and Relative Binding Free Energies. J. Comput. Aided. Mol. Des. 34, 99–119. 10.1007/s10822-020-00289-y [DOI] [PMC free article] [PubMed] [Google Scholar]
- Patel S., Brooks C. L., 3rd (2004). CHARMM Fluctuating Charge Force Field for Proteins: I Parameterization and Application to Bulk Organic Liquid Simulations. J. Comput. Chem. 25, 1–16. 10.1002/jcc.10355 [DOI] [PubMed] [Google Scholar]
- Patel S., Brooks C. L., III (2003). CHARMM Fluctuating Charge Force Field for Proteins: I Parameterization and Application to Bulk Organic Liquid Simulations. J. Comput. Chem. 25, 1–16. 10.1002/jcc.10355 [DOI] [PubMed] [Google Scholar]
- Paul F., Wehmeyer C., Abualrous E. T., Wu H., Crabtree M. D., Schöneberg J., et al. (2017). Protein-peptide Association Kinetics beyond the Seconds Timescale from Atomistic Simulations. Nat. Commun. 8, 1–9. 10.1038/s41467-017-01163-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Piniello B., Lira-Navarrete E., Takeuchi H., Takeuchi M., Haltiwanger R. S., Hurtado-Guerrero R., et al. (2021). Asparagine Tautomerization in Glycosyltransferase Catalysis. The Molecular Mechanism of Protein O-Fucosyltransferase 1. ACS Catal. 11, 9926–9932. 10.1021/acscatal.1c01785 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Piquemal J.-P., Chevreau H., Gresh N. (2007). Toward a Separate Reproduction of the Contributions to the Hartree−Fock and DFT Intermolecular Interaction Energies by Polarizable Molecular Mechanics with the SIBFA Potential. J. Chem. Theory Comput. 3, 824–837. 10.1021/ct7000182 [DOI] [PubMed] [Google Scholar]
- Plattner N., Noé F. (2015). Protein Conformational Plasticity and Complex Ligand-Binding Kinetics Explored by Atomistic Simulations and Markov Models. Nat. Commun. 6. 10.1038/ncomms8653 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pollard T. D. (2010). A Guide to Simple and Informative Binding Assays. MBoC 21, 4061–4067. 10.1091/mbc.E10-08-0683 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ponder J. W., Wu C., Ren P., Pande V. S., Chodera J. D., Schnieders M. J., et al. (2010). Current Status of the AMOEBA Polarizable Force Field. J. Phys. Chem. B 114, 2549–2564. 10.1021/jp910674d [DOI] [PMC free article] [PubMed] [Google Scholar]
- Potterton A., Husseini F. S., Southey M. W. Y., Bodkin M. J., Heifetz A., Coveney P. V., et al. (2019). Ensemble-Based Steered Molecular Dynamics Predicts Relative Residence Time of A2A Receptor Binders. J. Chem. Theory Comput. 15, 3316–3330. 10.1021/acs.jctc.8b01270 [DOI] [PubMed] [Google Scholar]
- Pratt L. R. (1986). A Statistical Method for Identifying Transition States in High Dimensional Problems. J. Chem. Phys. 85, 5045–5048. 10.1063/1.451695 [DOI] [Google Scholar]
- Proudfoot A., Bussiere D. E., Lingel A. (2017). High-Confidence Protein-Ligand Complex Modeling by NMR-Guided Docking Enables Early Hit Optimization. J. Am. Chem. Soc. 139, 17824–17833. 10.1021/jacs.7b07171 [DOI] [PubMed] [Google Scholar]
- Qiu Y., Smith D. G. A., Boothroyd S., Jang H., Hahn D. F., Wagner J., et al. (2021). Development and Benchmarking of Open Force Field v1.0.0-the Parsley Small-Molecule Force Field. J. Chem. Theory Comput. 17, 6262–6280. 10.1021/acs.jctc.1c00571 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ray D., Andricioaei I. (2020). Weighted Ensemble Milestoning (WEM): A Combined Approach for Rare Event Simulations. J. Chem. Phys. 152, 234114. 10.1063/5.0008028 [DOI] [PubMed] [Google Scholar]
- Ray D., Stone S. E., Andricioaei I. (2022). Markovian Weighted Ensemble Milestoning (M-WEM): Long-Time Kinetics from Short Trajectories. J. Chem. Theory Comput. 18, 79–95. 10.1021/acs.jctc.1c00803 [DOI] [PubMed] [Google Scholar]
- Regan J., Pargellis C. A., Cirillo P. F., Gilmore T., Hickey E. R., Peet G. W., et al. (2003). The Kinetics of Binding to p38MAP Kinase by Analogues of BIRB 796. Bioorg. Med. Chem. Lett. 13, 3101–3104. 10.1016/S0960-894X(03)00656-5 [DOI] [PubMed] [Google Scholar]
- Robustelli P., Ibanez-de-Opakua A., Campbell-Bezat C., Giordanetto F., Becker S., Zweckstetter M., et al. (2022). Molecular Basis of Small-Molecule Binding to α-Synuclein. J. Am. Chem. Soc. 144, 2501–2510. 10.1021/jacs.1c07591 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rocklin G. J., Boyce S. E., Fischer M., Fish I., Mobley D. L., Shoichet B. K., et al. (2013). Blind Prediction of Charged Ligand Binding Affinities in a Model Binding Site. J. Mol. Biol. 425, 4569–4583. 10.1016/j.jmb.2013.07.030 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Roston D., Demapan D., Cui Q. (2016). Leaving Group Ability Observably Affects Transition State Structure in a Single Enzyme Active Site. J. Am. Chem. Soc. 138, 7386–7394. 10.1021/jacs.6b03156 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rufa D. A., Bruce Macdonald H. E., Fass J., Wieder M., Grinaway P. B., Roitberg A. E., et al. (2020). Towards Chemical Accuracy for Alchemical Free Energy Calculations with Hybrid Physics-Based Machine Learning/Molecular Mechanics Potentials. bioRxiv, 1–21. 10.1101/2020.07.29.227959 [DOI] [Google Scholar]
- Salvalaglio M., Tiwary P., Parrinello M. (2014). Assessing the Reliability of the Dynamics Reconstructed from Metadynamics. J. Chem. Theory Comput. 10, 1420–1425. 10.1021/ct500040r [DOI] [PubMed] [Google Scholar]
- Schäfer T. M., Settanni G. (2020). Data Reweighting in Metadynamics Simulations. J. Chem. Theory Comput. 16, 2042–2052. 10.1021/acs.jctc.9b00867 [DOI] [PubMed] [Google Scholar]
- Schiebel J., Gaspari R., Wulsdorf T., Ngo K., Sohn C., Schrader T. E., et al. (2018). Intriguing Role of Water in Protein-Ligand Binding Studied by Neutron Crystallography on Trypsin Complexes. Nat. Commun. 9, 3559. 10.1038/s41467-018-05769-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schindler C. E. M., Baumann H., Blum A., Böse D., Buchstaller H.-P., Burgdorf L., et al. (2020). Large-Scale Assessment of Binding Free Energy Calculations in Active Drug Discovery Projects. J. Chem. Inf. Model. 60, 5457–5474. 10.1021/acs.jcim.0c00900 [DOI] [PubMed] [Google Scholar]
- Schlitter J., Engels M., Krüger P. (1994). Targeted Molecular Dynamics: A New Approach for Searching Pathways of Conformational Transitions. J. Mol. Graph. 12, 84–89. 10.1016/0263-7855(94)80072-3 [DOI] [PubMed] [Google Scholar]
- Schmidtke P., Luque F. J., Murray J. B., Barril X. (2011). Shielded Hydrogen Bonds as Structural Determinants of Binding Kinetics: Application in Drug Design. J. Am. Chem. Soc. 133, 18903–18910. 10.1021/ja207494u [DOI] [PubMed] [Google Scholar]
- Schneider D. (2022). The Exascale Era Is upon Us: The Frontier Supercomputer May Be the First to Reach 1,000,000,000,000,000,000 Operations Per Second. IEEE Spectr. 59, 34–35. 10.1109/MSPEC.2022.9676353 [DOI] [Google Scholar]
- Schramm V. L. (2015). Transition States and Transition State Analogue Interactions with Enzymes. Acc. Chem. Res. 48, 1032–1039. 10.1021/acs.accounts.5b00002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schramm V. L. (2013). Transition States, Analogues, and Drug Development. ACS Chem. Biol. 8, 71–81. 10.1021/cb300631k [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shan Y., Seeliger M. A., Eastwood M. P., Frank F., Xu H., Jensen M., et al. (2009). A Conserved Protonation-Dependent Switch Controls Drug Binding in the Abl Kinase. Proc. Natl. Acad. Sci. 106, 139–144. 10.1073/pnas.0811223106 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shaw D. E., Adams P. J., Azaria A., Bank J. A., Batson B., Bell A., et al. (2021). “Anton 3: Twenty Microseconds of Molecular Dynamics Simulation before Lunch,” in SC '21: The International Conference for High Performance Computing, Networking, Storage and Analysis. New York, NY, United States: Association for Computing Machinery. 10.1145/3458817.3487397 [DOI] [Google Scholar]
- Shen L., Yang W. (2018). Molecular Dynamics Simulations with Quantum Mechanics/Molecular Mechanics and Adaptive Neural Networks. J. Chem. Theory Comput. 14, 1442–1455. 10.1021/acs.jctc.7b01195 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shirts M. R., Chodera J. D. (2008). Statistically Optimal Analysis of Samples from Multiple Equilibrium States. J. Chem. Phys. 129, 124105. 10.1063/1.2978177 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Singh R., Wiseman B., Deemagarn T., Jha V., Switala J., Loewen P. C. (2008). Comparative Study of Catalase-Peroxidases (KatGs). Archives Biochem. Biophysics 471, 207–214. 10.1016/j.abb.2007.12.008 [DOI] [PubMed] [Google Scholar]
- Singhal N., Snow C. D., Pande V. S. (2004). Using Path Sampling to Build Better Markovian State Models: Predicting the Folding Rate and Mechanism of a Tryptophan Zipper Beta Hairpin. J. Chem. Phys. 121, 415–425. 10.1063/1.1738647 [DOI] [PubMed] [Google Scholar]
- Sinko W., Miao Y., de Oliveira C. A. F., McCammon J. A. (2013). Population Based Reweighting of Scaled Molecular Dynamics. J. Phys. Chem. B 117, 12759–12768. 10.1021/jp401587e [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sittel F., Stock G. (2018). Perspective: Identification of Collective Variables and Metastable States of Protein Dynamics. J. Chem. Phys. 149, 150901. 10.1063/1.5049637 [DOI] [PubMed] [Google Scholar]
- Spiriti J., Wong C. F. (2021). Qualitative Prediction of Ligand Dissociation Kinetics from Focal Adhesion Kinase Using Steered Molecular Dynamics. Life 11, 74–19. 10.3390/life11020074 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stelzl L. S., Kells A., Rosta E., Hummer G. (2017). Dynamic Histogram Analysis to Determine Free Energies and Rates from Biased Simulations. J. Chem. Theory Comput. 13, 6328–6342. 10.1021/acs.jctc.7b00373 [DOI] [PubMed] [Google Scholar]
- Stocker S., Csányi G., Reuter K., Margraf J. T. (2020). Machine Learning in Chemical Reaction Space. Nat. Commun. 11, 1–11. 10.1038/s41467-020-19267-x [DOI] [PMC free article] [PubMed] [Google Scholar]
- Suárez E., Wiewiora R. P., Wehmeyer C., Noé F., Chodera J. D., Zuckerman D. M. (2021). What Markov State Models Can and Cannot Do: Correlation versus Path-Based Observables in Protein-Folding Models. J. Chem. Theory Comput. 17, 3119–3133. 10.1021/acs.jctc.0c01154 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Svensson F., Engen K., Lundbäck T., Larhed M., Sköld C. (2015). Virtual Screening for Transition State Analogue Inhibitors of IRAP Based on Quantum Mechanically Derived Reaction Coordinates. J. Chem. Inf. Model. 55, 1984–1993. 10.1021/acs.jcim.5b00359 [DOI] [PubMed] [Google Scholar]
- Tang Z., Chang C.-e. A. (2018). Binding Thermodynamics and Kinetics Calculations Using Chemical Host and Guest: A Comprehensive Picture of Molecular Recognition. J. Chem. Theory Comput. 14, 303–318. 10.1021/acs.jctc.7b00899 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Teo I., Mayne C. G., Schulten K., Lelièvre T. (2016). Adaptive Multilevel Splitting Method for Molecular Dynamics Calculation of Benzamidine-Trypsin Dissociation Time. J. Chem. Theory Comput. 12, 2983–2989. 10.1021/acs.jctc.6b00277 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tiwary P., Mondal J., Berne B. J. (2017). How and when Does an Anticancer Drug Leave its Binding Site? Sci. Adv. 3, e1700014. 10.1126/sciadv.1700014 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tiwary P., Parrinello M. (2015). A Time-independent Free Energy Estimator for Metadynamics. J. Phys. Chem. B 119, 736–742. 10.1021/jp504920s [DOI] [PubMed] [Google Scholar]
- Tiwary P., Parrinello M. (2013). From Metadynamics to Dynamics. Phys. Rev. Lett. 111, 230602. 10.1103/PhysRevLett.111.230602 [DOI] [PubMed] [Google Scholar]
- Truhlar D. G., Garrett B. C., Klippenstein S. J. (1996). Current Status of Transition-State Theory. J. Phys. Chem. 100, 12771–12800. 10.1021/jp953748q [DOI] [Google Scholar]
- Unke O. T., Chmiela S., Sauceda H. E., Gastegger M., Poltavsky I., Schütt K. T., et al. (2021). Machine Learning Force Fields. Chem. Rev. 121, 10142–10186. 10.1021/acs.chemrev.0c01111 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Van Der Velden W. J. C., Heitman L. H., Rosenkilde M. M. (2020). Perspective: Implications of Ligand-Receptor Binding Kinetics for Therapeutic Targeting of G Protein-Coupled Receptors. ACS Pharmacol. Transl. Sci. 3, 179–189. 10.1021/acsptsci.0c00012 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Van Erp T. S., Moroni D., Bolhuis P. G. (2003). A Novel Path Sampling Method for the Calculation of Rate Constants. J. Chem. Phys. 118, 7762–7774. 10.1063/1.1562614 [DOI] [Google Scholar]
- Vanommeslaeghe K., Hatcher E., Acharya C., Kundu S., Zhong S., Shim J., et al. (2011). CHARMM General Force Field: A Force Field for Drug-like Molecules Compatible with the CHARMM All-Atom Additive Biological Force Fields. J. Comput. Chem. 31, 671–690. 10.1002/jcc.21367.CHARMM [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vauquelin G., Bostoen S., Vanderheyden P., Seeman P. (2012). Clozapine, Atypical Antipsychotics, and the Benefits of Fast-Off D2 Dopamine Receptor Antagonism. Schmiedeb. Arch. Pharmacol. 385, 337–372. 10.1007/s00210-012-0734-2 [DOI] [PubMed] [Google Scholar]
- Vitalini F., Mey A. S. J. S., Noé F., Keller B. G. (2015). Dynamic Properties of Force Fields. J. Chem. Phys. 142, 084101. 10.1063/1.4909549 [DOI] [PubMed] [Google Scholar]
- Votapka L. W., Jagger B. R., Heyneman A. L., Amaro R. E. (2017). SEEKR: Simulation Enabled Estimation of Kinetic Rates, A Computational Tool to Estimate Molecular Kinetics and its Application to Trypsin-Benzamidine Binding. J. Phys. Chem. B 121, 3597–3606. SEEKR. 10.1021/acs.jpcb.6b09388 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Voter A. F., Doll J. D. (1985). Dynamical Corrections to Transition State Theory for Multistate Systems: Surface -Self-Diffusion in the Rare-Event Regime. J. Chem. Phys. 82, 80–92. 10.1063/1.448739 [DOI] [Google Scholar]
- Voter A. F. (1997). Hyperdynamics: Accelerated Molecular Dynamics of Infrequent Events. Phys. Rev. Lett. 78, 3908–3911. 10.1103/PhysRevLett.78.3908 [DOI] [Google Scholar]
- Wan H., Voelz V. A. (2020). Adaptive Markov State Model Estimation Using Short Reseeding Trajectories. J. Chem. Phys. 152, 024103. 10.1063/1.5142457 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wang F., Landau D. P. (2001). Efficient, Multiple-Range Random Walk Algorithm to Calculate the Density of States. Phys. Rev. Lett. 86, 2050–2053. 10.1103/PhysRevLett.86.2050 [DOI] [PubMed] [Google Scholar]
- Wang J., Miao Y. (2020). Peptide Gaussian Accelerated Molecular Dynamics (Pep-GaMD): Enhanced Sampling and Free Energy and Kinetics Calculations of Peptide Binding. J. Chem. Phys. 153, 154109. 10.1063/5.0021399 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wang J., Wang W., Kollman P. A., Case D. A. (2006). Automatic Atom Type and Bond Type Perception in Molecular Mechanical Calculations. J. Mol. Graph. Model. 25, 247–260. 10.1016/j.jmgm.2005.12.005 [DOI] [PubMed] [Google Scholar]
- Wang J., Wolf R. M., Caldwell J. W., Kollman P. A., Case D. A. (2004). Development and Testing of a General Amber Force Field. J. Comput. Chem. 25, 1157–1174. 10.1002/jcc.20035 [DOI] [PubMed] [Google Scholar]
- Wang L., Wu Y., Deng Y., Kim B., Pierce L., Krilov G., et al. (2015). Accurate and Reliable Prediction of Relative Ligand Binding Potency in Prospective Drug Discovery by Way of a Modern Free-Energy Calculation Protocol and Force Field. J. Am. Chem. Soc. 137, 2695–2703. 10.1021/ja512751q [DOI] [PubMed] [Google Scholar]
- Wang Y., Martins J. M., Lindorff-Larsen K. (2017). Biomolecular Conformational Changes and Ligand Binding: from Kinetics to Thermodynamics. Chem. Sci. 8, 6466–6473. 10.1039/c7sc01627a [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wang Y., Valsson O., Tiwary P., Parrinello M., Lindorff-Larsen K. (2018). Frequency Adaptive Metadynamics for the Calculation of Rare-Event Kinetics. J. Chem. Phys. 149, 072309. 10.1063/1.5024679 [DOI] [PubMed] [Google Scholar]
- Wang Z. X., Zhang W., Wu C., Lei H., Cieplak P., Duan Y. (2006). Strike a Balance: Optimization of Backbone Torsion Parameters of AMBER Polarizable Force Field for Simulations of Proteins and Peptides. J. Comput. Chem. 27, 781–790. 10.1002/jcc.20386 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wolf S., Amaral M., Lowinski M., Vallée F., Musil D., Güldenhaupt J., et al. (2019). Estimation of Protein-Ligand Unbinding Kinetics Using Non-equilibrium Targeted Molecular Dynamics Simulations. J. Chem. Inf. Model. 59, 5135–5147. 10.1021/acs.jcim.9b00592 [DOI] [PubMed] [Google Scholar]
- Wolf S., Lickert B., Bray S., Stock G. (2020). Multisecond Ligand Dissociation Dynamics from Atomistic Simulations. Nat. Commun. 11, 1–8. 10.1038/s41467-020-16655-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wolf S., Stock G. (2018). Targeted Molecular Dynamics Calculations of Free Energy Profiles Using a Nonequilibrium Friction Correction. J. Chem. Theory Comput. 14, 6175–6182. 10.1021/acs.jctc.8b00835 [DOI] [PubMed] [Google Scholar]
- Woods C. J., Essex J. W., King M. A. (2003). Enhanced Configurational Sampling in Binding Free-Energy Calculations. J. Phys. Chem. B 107, 13711–13718. 10.1021/jp036162+ [DOI] [Google Scholar]
- Woods C. J., Manby F. R., Mulholland A. J. (2008). An Efficient Method for the Calculation of Quantum Mechanics/molecular Mechanics Free Energies. J. Chem. Phys. 128, 014109. 10.1063/1.2805379 [DOI] [PubMed] [Google Scholar]
- Wu H., Paul F., Wehmeyer C., Noé F. (2016). Multiensemble Markov Models of Molecular Thermodynamics and Kinetics. Proc. Natl. Acad. Sci. U.S.A. 113, E3221–E3230. 10.1073/pnas.1525092113 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Xue Y., Yuwen T., Zhu F., Skrynnikov N. R. (2014). Role of Electrostatic Interactions in Binding of Peptides and Intrinsically Disordered Proteins to Their Folded Targets. 1. NMR and MD Characterization of the Complex between the C-Crk N-SH3 Domain and the Peptide Sos. Biochemistry 53, 6473–6495. 10.1021/bi500904f [DOI] [PubMed] [Google Scholar]
- Yang M., Bonati L., Polino D., Parrinello M. (2022). Using Metadynamics to Build Neural Network Potentials for Reactive Events: the Case of Urea Decomposition in Water. Catal. Today 387, 143–149. 10.1016/j.cattod.2021.03.018 [DOI] [Google Scholar]
- Yue S., Muniz M. C., Calegari Andrade M. F., Zhang L., Car R., Panagiotopoulos A. Z. (2021). When Do Short-Range Atomistic Machine-Learning Models Fall Short? J. Chem. Phys. 154, 034111. 10.1063/5.0031215 [DOI] [PubMed] [Google Scholar]
- Yue Z., Wang Z., Voth G. A. (2022). Ion Permeation, Selectivity, and Electronic Polarization in Fluoride Channels. Biophysical J. 121, 1336–1347. 10.1016/j.bpj.2022.02.019 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhang B. W., Jasnow D., Zuckerman D. M. (2010). The “Weighted Ensemble” Path Sampling Method Is Statistically Exact for a Broad Class of Stochastic Processes and Binning Procedures. J. Chem. Phys. 132, 054107. 10.1063/1.3306345 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhao L., Ciallella H. L., Aleksunes L. M., Zhu H. (2020). Advancing Computer-Aided Drug Discovery (CADD) by Big Data and Data-Driven Machine Learning Modeling. Drug Discov. Today 25, 1624–1638. 10.1016/j.drudis.2020.07.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zuckerman D. M., Chong L. T. (2017). Weighted Ensemble Simulation: Review of Methodology, Applications, and Software. Annu. Rev. Biophys. 46, 43–57. Weighted. 10.1146/annurev-biophys-070816-033834 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.